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Abstract
3D-STIFFNESS MICROENVIRONMENT LEADS TO
NUCLEAR ENVELOPE RUPTURE, DNA DAMAGE, AND
GENOME VARIATION

Kuangzheng Zhu
Dennis E. Discher

Solid tumor cells grow in a stiff microenvironment with dense
extracellular matrix (ECM) and condensed packing of adjacent cells. Tumor
cells are capable of migrating through constricted pores formed by ECM or
surrounded by other cells, and the nuclear envelope can break with repair
factor mislocalization, further leading to DNA damage and genetic changes,
or even accumulated to be genomic variations. Cell division, likewise, is
confined by a stiff niche of adjacent cells and extracellular matrix, and such
confinement has been reported to cause chromosome mis-segregation. The
chromosome-loss live cell reporter system was developed to prove that cells
undergoing specific types of chromosome missegregation can survive and
xi

maintain heritability, resulting in permanent genomic variations. Mitotic cells
under in vitro confinement and in vivo conditions exhibit more abnormal
division and more fluorescence-null reporter-negative cells, for both cancer
and normal types. Confinement and SAC inhibition both lead to chromosome
mis-segregation but do not superimpose, and Topoisomerase IIa plays an
essential role in cells to survive after confined mitosis. Myosin II was found
to lead to increased nuclear envelope rupture and, therefore, more DNA
damage, while it protects mitotic cell rounding within 3D confined
environments, since the increase of reporter-negative cells was observed after
Myosin II knockdown.

Terminologies: nuclear envelope (NE), nuclear localization sequence (NLS), lamin,
myosin, chromosome (Chr), copy number variation (CNV), extracellular matrix (ECM),
aneuploidy, nocodazole (Noc), reversine, microtubule (MT), spindle assembly checkpoint
(SAC), topoisomerase
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Chapter 1
Background and introduction

1

1.Background and introduction

1.1 Mutation, repair factor, and DNA damage

Repair of DNA has developed along with evolution of organisms, with increasing
accuracy and more complicated machinery. RNA virus (represented by Covid) which
cannot even reproduce without a host, carries out point mutation at a rate of 10−3 to 10−5
per base per generation, not only because RNA chain lacks another strand to confirm its
parental chain, but also because its repairing machinery is underdeveloped (Peck and
Lauring, 2018; Agol and Gmyl, 2018). For bacteria or unicellular eukaryotes (like fungus
or protozoan) that are more developed than RNA-virus, the rate becomes 0.003 mutations
per genome per cell generation (Drake et al., 1998), translating to 10-9 to 10-10 mutation
per base per cell generation, 10 thousand to a million times more stable than that of
RNA-virus (sample calculation A1). We human beings normally carry out DNA base pair
mutation at a frequency of 10−8 per site per biological generation, translating to at least
10−20 per site per cell generation, at least 10 orders of magnitudes lower than that of E.
coli (Drake et al., 1998, sample calculation A1). DNA repair can be conducted in single
or double strands, and double-stranded DNA repair in mammals include homologous
recombination (HR) as well as non-homologous ending joining (NHEJ) pathways, both
of which are responsible for DNA repair in G1 and G2 phases to prepare for as precise
mitosis procedure as possible. In general, NHEJ is a less accurate machinery than HR,
with the latter requiring a DNA template while the former involving basic ligation of
2
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phospho-diester bond at the breaking backbone (Kakarougkas and Jeggo, 2014a), but
NHEJ does indeed play a major role in DNA repair before DNA synthesis in G0/G1
phase. Factors KU70 and KU80, for example, can form dimers and play an essential role
in NHEJ in G0/G1 phase (Kakarougkas and Jeggo, 2014a; Boulton and Jackson, 1998).
BRCA, 53BP1, msh family, and RPA, on the other hand, are involved in HR in various
degrees, which function in late S to G2 phases where DNA replication has completed
(Kakarougkas and Jeggo, 2014a; Boulton, 2006; Wang et al., 2001; Warmoes et al.,
2012; Wang et al., 2019; Chen and Wold, 2014; Yoshida and Miki, 2004). BRCA1 and
BRCA2 are also tumor suppressor genes, and are found to be mutated or non-functional
in breast cancer (Friedenson, 2007; O’Donovan and Livingston, 2010; Duncan et al.,
1998; Yoshida and Miki, 2004 ); 53BP1 binds to the famous, important tumor suppressor
gene p53 (Iwabuchi et al., 1994; Iwabuchi et al., 1998; Alberts, 2015); msh family
proteins are also tumor suppressors, and mutation in msh2 is related to hereditary
nonpolyposis colorectal cancer (Ring et al., 2017; de Wind et al.,1995). Since these DNA
repair factors are normally located inside the nuclear envelope, many of which display
tumor suppressor function, their mislocalization, leading to insufficient amount or
equivalent to down regulation, can be an interesting topic to study in terms of increased
DNA damage as related to cancer progression (Irianto et al., 2017; Kakarougkas and
Jeggo, 2014; Christmann and Kaina, 2000; von Morgen et al., 2018). In this sense, even
though eukaryotes developed nuclear envelope to compartmentalize important genetic
materials and relevant factors and enzymes, abnormal perturbation either intranuclear or
3
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transnuclear indirectly bring genetic errors back to the nucleic acids, which, in turn,
drastically inhibit the DNA replication error-correcting system.

1.2 Aneuploidy and genomic instability

Aneuploidy is the genomic status of a cell with an abnormal number of
chromosomes, and the total number of chromosomes is not a multiple of a normal
haploid of the organism. Human somatic cells are normally diploid, while many plant
organs can go triploid or even tetraploid in nature, but still maintain euploidy (Vignesh
Kumar et al., 2020; Zhang et al., 2019;Perrier et al., 2011). Aneuploidy, on the other
hand, is the status of unequal copy numbers among all homologous chromosomes.
Down’s Syndrome, for instance, gives trisomy (3 copies of a chromosome) in
chromosome 21, while 2 copies of the rest (Patterson, 2009). Many special sex status,
like Klinefelter syndrome (nicknamed “super male” ,XXY), and Turner Syndrome
(infertile woman, XO) are all results of aneuploidy in sex chromosomes (Klinefelter,
1986; Astwood, 2014; Gunther et al., 2004). Additionally, aneuploidy can exist with
more or fewer copies of partial chromosomes. Jacobsen Syndrome, for example, results
4
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from deletion of a band from the q-arm of chromosome 11 (Favier et al., 2015). All of the
above examples of aneuploidy occur pre-development. In other words, the abnormality in
chromosome numbers existed prior to fertilization in sperm or egg which had gone
through meiosis with chromosome non-disjunction (a kind of mis-segregation) or
inherited biological problems from spermatocytes or oocytes (Alberts, 2015). Therefore,
as a result of a fertilized egg that divided millions of cycles, diseased patients have all of
their somatic cells carrying those abnormal genomes. Unfortunately, many fetus with
chromosome miscarriage are lethal, and cannot live to birth, within which Down’s
syndrome has already given one of the highest rates of live birth cases (Driscoll and
Gross; Griffiths, 2005; Morris et al., 1999).

Cancer cells, however, survive with aneuploidy in many different formats (Duijf
et al., 2013; Rajagopalan and Lengauer, 2004; Hassold and Hunt, 2001). Two thirds of
human solid tumors are aneuploid (Duijf et al., 2013). Many of them result from
chromosome mis-segregation in mitosis, leading to chromosome losses or gains
(Nicholson et al., 2015; Santaguida et al., 2017). This process can persist for descendent
cells, especially if the lost chromosome contains many tumor suppressor genes and the
acquired chromosome contains oncogenes. Nonetheless, aneuploidy in other
chromosomes can also trigger it if the pathway of tumor-related genes is changed by
genes located on these chromosomes, or leading to mutations in tumor-related genes.
Additionally, the continued process of chromosome mis-segregation in aneuploid cancer
5
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cells would lead to genomically unidentical descendants with different phenotypes that
can potentially be selected for after chemotherapy drug and give rise to bad prognosis
(Schmitt et al., 2012; Mansoori et al., 2017; Nathanson et al., 2014; Benner et al., 1991;
Greaves and Maley, 2012). The mixture of cancer cells with heterogeneity in genotype
existent in a tumor is also termed as chromosomal mosaicism (Lichtenstein, 2018; Iourov
et al., 2019). Therefore, the mutation of cancer has been well-known to contribute
difficulties to cancer treatment. DNA damage, after all, represents one or some point
mutations in nucleotide base pair and, therefore, amino acids, while Chromosome Copy
Number Variation (CNV) leads to the change of genes in the entire chromosome or at
least portion of it, covering thousands of genes and the proteins expressed by them (Yao
and Dai, 2014; Northcott et al., 2017; Bittel and Butler, 2005; Shlien and Malkin, 2009;
Zheng et al., 2020).

1.3 Endogenous mechanical perturbations

Biochemical and radiational perturbations have been ubiquitously admitted as a
major exogenous source of cancer formation and progression (Holt, 1979; Tomasetti et al.,
6

1.3 Endogenous mechanical perturbations

2017a). Exogenous chemical processes, such as drinking alcohol, inhaling carcinogenic
odor, and consuming heavily grilled meat product, have been frequently reported to lead
to cancer, by increasing the chances of building up malignant genomic and genetic
mutations , including but not limited to carcinogens binding to DNA or their repair factors,
inhibiting function of mitotic proteins or tumor suppressors (Jiang et al., 2007; Ratna and
Mandrekar, 2017; Pfeifer et al., 2002; Seitz and Stickel, 2007). Nonetheless, DNA damage
and genome alterations can be triggered not only chemically but also mechanically. Cancer
cells can migrate when ECM gives abnormal stiffness, which then leads to metastasis (Eble
and Niland, 2019; Fattet et al., 2020; Najafi et al., 2019; Bonnans et al., 2014). Other than
alcohol, cirrhosis also contributes significantly to liver cancer, providing stiff environment
for liver cells (GBD 2013 Mortality and Causes of Death Collaborators, 2015; Chung et
al., 2018; Dooley et al., 2018a), with extracellular matrix (Dooley et al., 2018b; Parola and
Pinzani, 2019; Schwabe et al., 2020), and this could be traced back to earlier fat liver
diseases where lipid droplet can squeeze and change the shape of organelles, including
nuclei (Castera et al., 2019; Farrell and Larter, 2006).

High stiffness is found to be

frequently associated with increased genomic instability and enhanced mutation in cancer
(Pfeifer et al., 2017a; López-Carrasco et al., 2020; Deville and Cordes, 2019). Tumor cells
frequently pass through tortuous and constricted space formed by convoluted ECM without
degrading it or releasing its tension, which further leads to breaking of nuclear envelope at
high-curvature sites followed by repair factor mislocalization (Song et al., 2016; Iredale,
2003; Jackson et al., 2017; Lamalice et al., 2007; Xia et al., 2018; Irianto et al., 2017a, Fig.
7
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1.1,1.2). Additionally, cell division under a high-stiffness tumor environment is a possible
reason leading to more genomic variation (Fig. 1.1), since recent studies have disclosed
that tumors with higher stiffness and more times of divisions are associated with more
potential genomic variation (Deville and Cordes, 2019; Pfeifer et al., 2017b), and abnormal
mitosis have been seen in many tumor biopsies (Jin et al., 2007; Sun et al., 2003), in
contrast to stem cell mitosis in soft substrate such as bone marrow that doesn’t give rise to
error in cell division before differentiation (Swift et al., 2013; Pfeifer et al.,
2017a;Tomasetti et al., 2017b).

Endogenous, direct molecular mechanisms of cancer formation and progression
include but are not limited to overexpression of oncogenes and downregulation or even
deletion of tumor suppressors (Weinberg, 2014; Liu et al., 2015; Mo et al., 2020; Payne
and Kemp, 2005; Wang et al., 2020; Wang et al., 2016). However, interestingly, some
cancer cells have normal tumor suppressor genes, like A549 cell line have normal p53
expression (Guo et al., 2014; Guntur et al., 2010). In this case, loss of tumor suppressor
isn’t the only way through which chromosomal gains and losses occur, while
mechanically generated chromosomal CNV plays an important role. Realistically, tumor
suppressor mutation and mislocalization of repair factors with tumor suppressor functions
still contribute significantly to tumorigenesis, but their mutual cause-and-effect
relationship with mechanical stress should be emphasized. In other words, overexpression
of oncogene and deletion of tumor suppressor gene can result from completely
8
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Figure 1.1: Schematic of the mechano-microenvironment of tumor cells. Tumor cells are
densely packed in 3D stiff environment composed of ECM and adjacent cells. They migrate
through constricted space formed by ECM (made of collagen, hyaluronic acid, etc) and result
in DNA damage due to nuclear envelope rupture, and also undergo mitosis under confined
space surrounded by adjacent cells and ECM, leading to chromosome copy number changes.
9
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spontaneous random mutation, and can also be triggered by mechanical stress induced
DNA damage or even chromosome copy number changes.

1.4 Myosin, microtubule, and Topoisomerase II

Thousands of proteins and factors work chemically and mechanically to stretch or
compress cells and nuclei, provide them with protection and required functions to pursue
the ultimate most important goal of biology---intactness of genetic material. In this study,
we focus on non-muscle myosin, microtubule, and topoisomerase II.
As one of the first motor proteins to be discovered, myosin family proteins are well
known for their ability to facilitate actin movement when energy is consumed through ATP
hydrolysis on the head domains (Alberts, 2015; Hayashida et al., 1991). Different myosins
constitute generally identical functions with subtle nuances which are enough to carry out
different physical behaviors when involved in cell movement and motility (Raab et al.,
2012; Pollard and Ostap, 1996). Actin functions in polymer, and also needs active
contractility, for which myosin and actin work synergistically as actomyosin system which
plays a significant role in cell stretching and migration (Raab et al., 2012), as well as
10
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Figure 1.2: Schematic of compression leading to nuclear envelope rupture and DNA
damage. Cells migrate through small pores or experience compressing force, high
curvature spots formed on nuclear envelope undergo rupture with DNA repair factors
(including KU70,KU80, BRCA1, BRCA2, RPA1, msh2, etc) flowing into the cytoplasm,
which then leads to DNA damage.

11
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Figure 1.3: Schematic of Myosin’s effect on mechanical aspects of cell and nuclear shape.
(A) myosin facilitates contraction and stretching of actin. Inhibition or depletion or inhibition
of myosin leads to reduced or no actin contractility, giving nucleus and cell rounder shape;
overexpression of it leads to enhanced stretching, providing cell and nucleus with elongated
shape, with possible NE rupture on the site with high curvature. (B) actomyosin protects
mitotic cell rounding shape against compressing forces from adjacent environment, without
which the rounding can collapse and chromosome mis-segregation occur as a result.

protection of cell rounding cortex (Stewart et al., 2011). Inhibition of myosin gives similar,
if not excessive, effects as drug-induced (latrunculin) actin depolymerization in many cases
(Lancaster et al., 2013; Hu et al., 2019; Doller et al., 2015). Overexpression of myosin
provides cells with more contractility, and is capable of stretching the nuclear envelope to
break with increased elongation and distortion, vise versa (Fig. 1.3A). On the other hand,
however, actomyosin generates force to protect mitotic cell rounding against compressing
forces from external conditions, which helps maintain genome intactness by reducing
errors in cell division (Fig. 1.3B). In this case, there seems to be a paradox that more myosin
leads to increase in DNA damage in interphase cells but reduces chances of genomic
instability after mitosis. Indeed, myosin plays a role in tumorigenesis (Ouderkirk and
Krendel, 2014; Li and Yang, 2016), but is also categorized as tumor suppressor in some
cases (Coaxum et al., 2017; Mazzolini et al., 2012), exhibiting a dilemma, yet unclear
judgement of the protein, based upon many more pathways involved than the focus in our
study (Wang et al., 2019). Nonetheless, the degree to which the genome is changed as a
net consequence from the combination of NE rupture, abnormal mitosis under
confinement, and other pathways, is the key to cancer generation and progression. The

13
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degree may vary from case to case, giving myosin different directions in response to
tumorigenesis.

Similar to myosin and actin, microtubule plays important roles in interphase as to
cell movement and is one of the most essential mitotic proteins. Microtubule moves with a
treadmilling process, with alpha, beta tubulins incorporated and eliminated alternatively
(Alberts, 2015) from plus and minus ends, respectively. In mitosis, dynamics of
microtubules allows chromosomes to be aligned properly at metaphase, as well as
separation of sister chromatids. Both permanent disassembly (nocodazole, colchicine) and
stability (paclitaxel) of microtubules prevent mitosis from proceeding, so both colchicine
and paclitaxel can work as chemotherapy drugs in terms of prohibiting tumor cells from
proliferating. Moreover, the length of the microtubule is critical for proper equatorial
alignment of chromosomes (Lancaster et al., 2013; Dumont and Mitchison, 2009; Kapoor,
2017). Within a mitotic cell, Microtubule is emitted from the microtubule organization
center (MTOC) with centrioles, and its length is controlled by the speed at which tubulins
are assembled or disassembled. Confined space increases the cross-sectional area of mitotic
cells, for which the original length of microtubule cannot fill the gap between MTOC and
kinetochore (Dumont and Mitchison, 2009). Therefore, without proper microtubule
attachment, chromosome alignment and sister chromatid segregation fail to proceed,
leading to genomic variation.

14
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The family of topoisomerase proteins contribute to DNA unwinding or untangling
during cell cycle including but not limited to mitosis through single or double strand
mechanisms where the backbone is temporarily broken and reannealed. Topoisomerase I,
for instance, works with the single-strand annealing mechanism in interphase where DNA
is being replicated (Alberts, 2015., (Girstun et al., 2017; Znojek et al., 2014).
Topoisomerase II, on the other hand, unwinds DNA by breaking both strands, and is
especially useful in mitosis to prevent sister chromatids from entangling and maintaining
chromosome structures (Lee and Berger, 2019; Nielsen et al., 2020; Gemble et al., 2020).
Our study finds that survived cells with specific genomic variation after passing through
mitosis under confinement reveals an increase in Topoisomerase II expression than the
same type of cells produced spontaneously, indicating that the protein is important in
keeping the relative intactness of chromosome and disentangle them to pass through
mitosis. It is not difficult to imagine that the extraordinary burden applied by confined
space adds to more chances for chromosomes to entangle, and cells happening to express
more Topoisomerase II can survive with less chromosomal damage, despite the result as
genomically altered individuals.

1.5

Conclusion and outline
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It has been stated prevalently that genetic and genomic errors accumulate for cancer
formation and progression, and, in the past years, mechanobiological perturbations other
than traditionally perceived biochemical and radial toxification have been gradually
accepted as important causes of carcinogenesis. Nuclear envelope rupture, stated above as
a process through which DNA becomes insufficiently repaired, is highly associated with
abnormal quantity or behavior of cytoskeleton and associated proteins that introduce
excessive mechanical stress, amplify pre-existing stress, and function simultaneously to
yield superimposed effect. Even though DNA mutation yielded by mis-repair represents
small-scale point mutation, its accumulation along with side effects of mis-repair can still
have an effect on chromosome copy number variation (Irianto et al., 2017). Another
important cause, or perhaps the main cause of CNV involves mitosis within a stiff 3D
substrate (Pfeifer et al., 2017a). The increasing interest in cancer genomic instability or
mosaicism have made popular use of microarray, single cell genome or transcriptome
sequencing, and mass-spectroscopy, while the above methodologies require that cells be
killed after which genetic material and peptides can be extracted. All cells to be studied
have their biological processes terminate at the time of analysis, similar to the effect of
Western blot, Immunofluorescence, and FISH (Mahmood and Yang, 2012; Mandrell et al.,
1988; Langer-Safer et al., 1982). Therefore, our research provides a new method----Live
Cell Chromosome Loss Reporter---to study genomic variation. In this case, genomically
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altered cells with known chromosomes can keep growing after imaging or flow cytometry,
and can also be accurately sorted and traced for heritability.

Since the background of mechanobiological causes of genomic instability was
emphasized and introduced, the thesis now proceeds with the following logic: chapter 2
tends to describe cytoskeleton and ECM-introduced mechanical stress, along with and the
brief mechanisms under which nuclear envelope rupture happens, followed by the effect
on repair factor mislocalization and DNA mis-repair. More severe consequences—
chromosome copy number variation, as a result of consecutive, repeated nuclear envelope
rupture and DNA mis-repair, will also be discussed. In chapter 3, the design, fundamental
ideas, and basic uses of the live cell chromosome reporter system will be introduced, to
provide the basis of the new approach used in the more in-depth research related to the
biophysical conditions leading to mitotic error, and, as a result, genomic variation. The
reporter system is to be validated in that, 1. the loss of chromosomes can be accurately
reflected by fluorescence color loss in cell; 2. Events with more mitotic error lead to more
cells with color loss. In chapter 4, the topic of mitosis under confined space—an in vitro
construct that mimics mitosis under stiff substrates in vivo--will be concentrated. The fact
that mitosis under confined space leads to more mitotic error, and, therefore, an increase
in genomic variation. Some molecular mechanisms of confinement-induced mitotic
mistakes will be studied and discussed, including what proteins are up or down regulated
after confinement, how mitosis under confinement is protected, and how confinement is
17
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related to spindle assembly checkpoint inhibition in introducing aneuploidy. The viability
and heritability, as a marker of presumably survived, mutated cancer cells, after
perturbations including confinement, will also be displayed. In chapter 5, reporter cells in
vivo as xenografts will be studied, to find out how and to what stage genomic variation is
triggered by real somatic conditions where tumor forms, and how heritable they are.
Moreover, some phenotypic changes as a result of chromosomal changes are revealed
and analyzed.
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Chapter 2
Mechanical Stress leads to nuclear
envelope rupture and DNA damage
Data in Fig. 2.1 to 2.6 in this chapter have been published in Nuclear rupture at sites of
high curvature compromises retention of DNA repair factors. The Journal of Cell
Biology, 2018, 217(11), 3796–3808, by Xia, Y., Ivanovska, I.L., Zhu, K., Smith, L.,
Irianto, J., Pfeifer, C.R., Alvey, C.M., Ji, J., Liu, D., Cho, S., Bennett, R.R., Liu, A.J.,
Greenberg, R.A., Discher, D.E.; data in Fig. 2.7 to 2.8 A-B have been published in
Rescue of DNA damage after constricted migration reveals a mechano-regulated
threshold for cell cycle. The Journal of Cell Biology, 2019,218(8), 2545–2563, by Xia,
Y., Pfeifer C.R., Zhu K., Irianto J., Liu D., Pannell K., Chen E.J., Dooling L.J., Tobin
M.P., Wang M., Ivanovska I.L., Smith L.R., Greenberg R.A., Discher D.E.. Dr.Yuntao
Xia conducted analysis in Fig. 2.1, executed Fig. 2.3; Dr. Irena Ivanovska conducted
AFM in Fig. 2.1; Fig. 2.2 was drawn by Dr. Dennis Discher; Dr. Jerome Irianto
conducted Fig. 2.8 A & B. Kuangzheng Zhu plated and transfected cells for Fig. 2.1,
and conducted experiments for all the rest of the figures.
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2.1

Introduction

DNA damage and repair are ongoing in cell nucleus, and delayed repair along
with insufficient repair are capable of leading to cumulative DNA damage, which is a
source of cancer cell formation, mutation, and cell aging. One important source of DNA
mis-repair is mislocalization of nuclear repair factors. In breast cancer cells, for instance,
multiple repair factors mislocate, such as BRCA1 (Alshareeda et al., 2016). A
conceivable mechanism for repair factor mislocalization is rupture of the nuclear
envelope, as a result of increased mechanical stress, and the effect is further contributed
by less sturdy nuclear envelope and/or increased curvature. Many cancer cells grow in
stiff environment with overexpressed amount of ECM that leads to increased stretching,
and some cancer cells (Alshareeda et al., 2016) or even abnormal somatic cells (e.g.
progeria cells, de la Rosa et al., 2013) express insufficient than normal level of lamin A,
leading to nuclei with reduced sturdiness (Capo-chichi et al., 2011) . High curvature, on
the other hand, can occur when the nucleus undergoes squishing forces in an ECM
network with limited pore size, and can result from mechanical stretching itself.
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2.2

High curvature and increased contractility lead to

NE rupture, repair factor mislocalization, and DNA
damage

Lamina forms a protective structure inside the nucleus to provide it with
physical strength, with lamin A/C and lamin B displaying different morphology and
structural arrangement within the nuclear envelope. Nuclei in live U2OS osteosarcoma
cells were probed with atomic force microscopy (AFM) tips of either medium or high
curvature (4.5-µm sphere or pyramidal tip <0.1-µm diameter; Fig. 2.1, A and B). The
force was held constant in a poly nano-Newton (nN) range similar to the contractile
forces generated by cells (Saez et al., 2005). Nuclear factors that are known to be mobile
within the nucleus were observed simultaneously with probing: these included YFP-NLS
and GFP fusions of DNA repair factors 53BP1 and KU80 (Fig. 2.2). Sudden
mislocalization to cytoplasm was frequently evident when probing with medium
curvature tips after lamin A knockdown (Fig. 2.4 A), whereas WT nuclei required highcurvature tips (Fig. 2.1, A and B, bar graph). YFP or GFP signal filled the cytoplasm for
minutes even after release of the AFM tip (Fig. 2.1 B, inset).
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A

Figure 2.1:Highcurvature probes
rapidly rupture
Nuclei, and LMNA
protects nuclei from
rupturing.
(A) Probing nuclei in
living WT U2OS cells
at constant force
(∼10–20 nN) with
medium-curvature
beads (diameter = 4.5
µm) shows no YFPNLS mislocalization
(inverse grayscale),
whereas lamin A
knockdown
(siLMNA) causes
frequent
mislocalization (bar
graph).

B

(B) High-curvature
tips (diameter < 0.1
µm) rupture WT
nuclei, based on
mislocalization of
YFP-NLS or GFP53BP1 into cytoplasm
within minutes (10/15
ruptured for GFP53BP1 and 4/6
ruptured for YFPNLS). Intensity
profiles show
decreased nuclear
signal and higher
cytoplasmic signal.
Inset: Cytoplasmic
GFP accumulates
even after probe tip is
removed. All scale
bars = 10 µm
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Figure 2.2: Schematic diagram of DNA misrepair leading to DNA damage. Various
DNA repair proteins may be affected when the nuclear envelope ruptures. DNA
damage triggers Histone component monomer H2AX to be phosphorylated, named
γH2AX.

This indicates that both high curvature and depletion of lamin A lead to nuclear envelope
rupture,and lamin A protects against high-curvature induced rupture. Repair factor
relocalizes more slowly than NLS with lower weight (Fig. B1). Partial knockdown of
lamin A with shLMNA was stably achieved in A549 lung carcinoma cells, whereas
shLMNA-treated U2OS cells showed a growth defect (Fig. 2.4 B). These cells grew
23
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A

B

C

Figure 2.3: When lamin A is low in spreading cells, NE ruptures at high curvature site,
enriched in lamin-A but depleted in lamin B. (A) Ruptured A549 shLMNA nuclei show high
cytoplasmic KU80 by immunofluorescence; the lamina is focally enriched in lamin A (arrow) and
depleted in lamin B. scale bar = 10 µm. (B) 92% of rupture events occur at poles of nuclei where
curvature is high. Cartoon shows 2D curvature in cells. (Continued next page)
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Figure 2.3: (Previous page) (C) Ruptured nuclei have lower circularity, indicating high
curvature. Overall nuclear area remains the same. n > 150 cells in three experiments. * p <
0.05, n.s., not significant.

normally (Fig. 2.4 C), but ∼10–20% of nuclei exhibited KU80 mislocalization in cells on
rigid coverslips (Fig. 2.4 D). A relationship with nuclear curvature was evident: the
lamina was disrupted at nuclear poles with enrichment of the residual lamin A and
depletion of lamin-B (Fig. 2.3 A and B). Ruptured A549 nuclei were also more
elongated, with lower nuclear circularity compared with nonruptured nuclei, while
nuclear area was constant (Fig. 2.3 C). Immunostaining for the DNA damage marker
γH2AX (Darzynkiewicz et al., 2011) together with KU80 indeed shows KU80
mislocalization tends to correlate with excess γH2AX foci in the shLMNA cells (Fig.B2,
A & B). DNA damage foci were randomly distributed throughout the nucleoplasm rather
than concentrated near sites of high-curvature lamina disruption (Fig. B2). Stable
expression of GFP-LMNA rescued knockdown cells, and an electrophoretic comet assay
for DNA damage confirmed the imaging (Fig. B2). Such a distribution is consistent with
impeded repair of dispersed DNA damage.
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Figure 2.4: Lamin A knockdown can affect cell growth and increase chances of repair
factor mislocalization. (A) Approximately 90% of lamin A protein is depleted after siRNA
treatment against LMNA. n = 3 experiments. (B) U2OS cells were transduced with shLMNA
via lentiviral delivery. Some heterogeneity in lamin A levels was observed after shLMNA
transduction, but the higher lamin A population dominates after long-term culture. (C) No
difference in proliferation rate was observed between A549 Ctl and shLMNA cells. n = 5
experiments. (D) Approximately 20% of A549 shLMNA cells show mislocalization of KU80
when cultured on plastic. Arrows point to cells with DNA repair factor that is low in nucleus
and high in cytoplasm. n > 5 fields of view per group in five experiments. Ctl, control.

DNA damage resulting from mislocalization of repair factors can be rescued by
overexpression of endo-nuclear DNA repair factors. Expression plasmids for these three
repair factors were thus pooled for cooverexpression (denoted GFP-3, KU70, KU80,
BRCA1) in U2OS lamin A–knockdown cells (Fig. 2.5 C). GFP-53BP1 was used as a
negative control (Ctl) because neither its overexpression nor si53BP1 affect DNA
damage (Fig. B3). Rupture was assessed by cytoplasmic mislocalization of endogenous
DNA repair factors or GFP fusions, and the latter transfections did not alter the ∼10% of
ruptured cells in fixed cultures (Fig. 2.5 A). Even with rupture, nuclear GFP signal was
intense relative to antibody staining for repair factors. For ruptured nuclei with
cytoplasmic KU80 or GFP-53BP1, DNA damage was in equal excess, but GFP-3 rescued
excess damage (Fig. 2.5 B). For nonruptured nuclei, GFP-3 had no effect on basal DNA
damage (Fig. 2.5 B), and so the three DNA repair factors are not limiting except when the
nucleus ruptures.

Myosin is a motor protein driving the function of actin, and the stretching of actin
provides nucleus with shape deformation and elongation. Overexpression of nonmuscle
27
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A

B

C

Figure 2.5: Co-overexpression of repair factors rescues DNA misrepair resulting from NE
rupture. (A) siLMNA-U2OS cells were fixed after 24 h DNA repair factor transfection and
immunostained for γH2AX. The nontransfected (NT) sample was also stained for KU80.
Cytoplasmic mislocalization of the GFP or KU80 identifies ruptured nuclei. (B) Bar graph:
Cotransfection of DNA repair factors KU70, KU80, and BRCA1 (GFP-3) rescues excess DNA
damage in ruptured nuclei, whereas ruptured nuclei with GFP-53BP1 (and NT) maintain excess
DNA damage. Nonruptured cells always show a basal level of DNA damage. n = 30–100 cells
per condition in three experiments. *p < 0.05; n.s., not significant. (C) Overexpression levels in
GFP-3 U2OS cells. n = 3 experiments. IF, immunofluorescence; NT, nontransfected. All scale
bars = 10 µm.
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A

B

D

C

E

Figure 2.6: Increased actomyosin stress can increase nuclear curvature, frequency of nuclear
envelope rupture, and DNA damage. (A)-(B) Compared with dominant-negative mutant (myosin
IIA–Y278F) and Blebbstatin, overexpression of myosin IIA or IIB in WT U2OS cells increases nuclear
rupture. (C)-(D) DNA damage increases in myosin IIA and myosin IIB overexpressed cells, evaluated
by both gama-H2AX and comet assay. (E) Blebbistatin treatment leads to more rounded nuclei as
shown by the increased nuclear circularity and reduced nuclear area (log scale). n > 100 cells per
condition in four experiments. *p < 0.05; n.s., not significant. Scale bar=10 µm.
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myosin II in WT U2OS cells with normal lamin A levels increase the number of cells
with ruptured nuclei characterized by mislocalized KU80, in drastic comparison with
overexpression of dead mutant Myosin IIA (Fig 2.6).

Moreover, as a result of GFP-myosin overexpression, DNA damage increases as
evaluated by both γH2AX foci count and comet assay (Fig. 2.6. C & D). Blebbistatin, as
a myosin II inhibitor, can rescue the effect in both cell shape resilience and DNA damage
decrease (Fig. 2.6).

2.3

Constricted migration leads to chromosome copy

number changes with repetitive NE rupture

3D Constricted migration through limited pore size is another important condition
of forming a high curvature spot on the nuclear envelope with temporary depletion of
lamin-B, and, therefore, leading to mis-segregation of repair factors. Essentially, all
U2OS or A549 cancer cell lines undergo nuclear rupture after small pore constricted
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A

B

Figure 2.7: Composition of blebs at rupture site. (A) Endogenous cGAS binds to DNA in
nuclear blebs, as seen in repre-sentative images of U2OS cells after 3-µm poremigration.
DNA damage foci do not localize to blebs, the sites of cGAS accumulation. (B)
Representative imagesof 3-µm pore–migrated U2OS cells show that nuclear blebs have
abundant acetylated chromatin. All scale bars=10 µm.
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migration (Irianto et al., 2017), at a much higher degree than perturbed by 2D LMNA
knockdown or increased mechanical stress. Anticorrelated distributions of lamin A and B
occur at sites of nuclear rupture (also at nuclear poles) during constricted migration
(Harada et al., 2014; Denais et al., 2016, 2.7B). The bleb also immunostains for acetylhistone-H3 (Fig. 2.7B), which is a likely marker of euchromatin (Bannister and
Kouzarides, 2011) and could relate to the restricted binding of cGAS--an exo-nuclear
DNA degrading factor--to the bleb, reaffirming the broken site where DNA is exposed to
extranuclear environment. 3-µm pores have smaller diameter than 8-µm pores and can,
therefore, lead to higher curvature of nuclei after cells migrate, which then lead to more
repair factor mislocalization and DNA mutation.

Chromosome mis-segregation happens after cycles of constricted migration. A549
cells were migrated three times through either 3 or 8-µm pores, including detachment and
expansion, with a final expansion of randomly chosen single cells to ∼1000,000 cells for
genomic analyses (Fig. 2.8A). Although all 10 randomly chosen clones obtained after
migration through 8-µm pores or from non-migrated 2D control cultures were statistically
the same, 3 of 5 clones obtained after migration through 3-µm pores differed significantly
from the others and each other (Fig. 2.8B). In previous studies, genome sequencing
methodology has been conducted on A549 cell lines undergoing constricted migration for
17 times and conveys distinctive variation in chromosome copy numbers across different
clones expanded from single cells (Irianto et al., 2017). Single Nucleotide Polymorphism
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Figure 2.8: (Previous page) Constricted migration and repair factor knockdown both lead
to genomic variation based on SNP array. (A) Schematics: A549 cells were subjected to three
rounds of Transwell migration through 3- or 8-µm pores to test the hypothesis that at least some
DNA damage would be survivable but misrepaired. Nonmigrated control clones were expanded
in parallel. From among these thrice-migrated or nonmigrated cells, the genomes of multiple
single cell–derived clones were quantified by SNP array analysis. Time span and doublings for
each step are indicated. (B) Compared with a clone that migrated three times through 8-µm pores,
significant chromosome copy number changes (ΔCN) and loss of heterozygosity (ΔLOH) above
the noise level (40 Mb) are observed in three of five A549 clones that migrated through 3-µm
pores. Clones are listed per hierarchical clustering of their ΔCN, and the asterisk indicates
statistical significance in the overall distribution of gains (red) and losses (green); *p< 0.05 in
Kolmogorov-Smirnov (KS) test (see Materials and methods, Genome (SNP array) analysis for
details), n.s., not significant. (C) Schematics: A549 cells (bulk culture) were subjected to
Knockdown of repair factors (si3) or Knockdown vehicle Ctrl (siCtrl), 4 clones from each
condition were randomly picked, expanded, and performed SNPa as in (B). An arbitrary clone
picked from A549 bulk without any perturbation was performed SNP array 3 times, to be used as
technical noise basal level. (D) Distribution of the standard deviation (STDEV) for all measured
gene loci: for each one of the five conditions, the STDEV of the copy number value of each gene
locus of the clones’ SNPa is calculated. The higher STDEV indicates more genomic and genetic
variation. n=2908 Mega Base Pair (Mb) per condition, total number of detectable loci of each 1
million base pairs of genome. Two-tailed t-test with Welch’s correction: ****p < 0.0001; ns, nonsignificant.

of A549 Cell Clones extracted from the bulk with repair factor knockdown
(si3,knockdown of KU70, BRCA1, and BRCA2), also shows more variation of each gene
locus and also copy number variations. Such phenomenon correlates depletion of repair
factor with NE rupture through constricted migration (Fig 2.8 C, D, B4). Moreover, siRepair factors leads to an increase in chromosome mis-segregation during mitosis, a
potential cause of aneuploidy (Fig. B5).

2.4

Discussion
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Mechanical stress on a strongly bended nucleus is highly likely to trigger nuclear
envelope rupture. For medium to high nuclear curvature, lamin A has a protective role
under AFM probing (Fig. 2A) and in adherent cells: in particular, shLMNA and Ctrl
A549 cells show no significant difference in circularity as a measure of nuclear curvature
(Fig. B3), and yet nuclear rupture is favored with low lamin A (Fig. 2.3; Fig. B2; Fig. 2.5;
Pfeifer et al., 2017).

External mechanical perturbations like contractility and squeezing interaction
imposed by excessive actomyosin function and constricted pore add to the extent to
which nuclei bend and form sites with high curvature (Fig. 2.6; Fig. 2.8). The excess
DNA damage quantified in this study indeed shows unusual upstream contributions from
ECM rigidity and actomyosin contractility via mechanisms involving curvature-induced
lamina break and loss of DNA repair factors.

Constricted migration through low-diameter transwell leads to DNA damage, as a
result of relatively high curvature imposed on nuclei. Repetitive repair factor
mislocalization as a result of cycles of constricted migration causes chromosome copy
number changes, because mis-segregation of DNA repair factors with native functions in
keeping chromosomal intactness (Difilippantonio et al., 2000; Wang et al., 2005; Irianto,
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et al., 2017), and possibly because some chromosomes contain too much mis-repair of
their genes to be repaired and kept in the genome anymore. This mimics cancer cells
migrating through confined space formed by ECM during metastasis and, finally
generating tumor genome variations. The fact that repair factor knockdown can lead to
increased chromosome-mis-segregation gives an insight to an important path for cancer
mutation.

2.5 Materials and methods

Cell lines and tissue culture
The following cancer cell lines for this study were: A549 lung adenocarcinoma and U2OS
osteosarcoma. The A549 and U2OS cell lines were obtained from the American Type
Culture Collection (ATCC). A549 cells were cultured in Ham’s F-12 media (Gibco
11765047); U2OS cells in DMEM (Gibco, Catalog no. 10569010). All aforementioned cell
lines were cultured in media supplemented with 10% (v/v) fetal bovine serum (FBS;
MilliporeSigma, Catalog no. F2442) and 100 U ml-1 penicillin-streptomycin (Gibco,
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Catalog no. 15140122). All cells were passaged every 2-3 days using 0.05%
Trypsin/EDTA (Gibco, Catalog no. 25300054). All cell lines were incubated at 37 oC and
maintained at 5% CO2.
Immunostaining
Cells were fixed in 4% formaldehyde (MilliporeSigma) for 15 min followed by 15-min
permeabilization by 0.5% Triton X-100 (MilliporeSigma), 30-min blocking by 5% BSA
(MilliporeSigma), and overnight incubation in primary antibodies at 4°C. The antibodies
used include lamin A/C (1:500; mouse; sc-7292; Santa Cruz Biotechnology, Inc.), lamin
A/C (1:500; goat; sc-6215; Santa Cruz Biotechnology, Inc.), lamin B (1:500; goat; sc6217; Santa Cruz Biotechnology, Inc.), γH2AX (1:500; mouse; 05-636-I;
MilliporeSigma), 53BP1 (1:300; rabbit; NB100-304; Novus Biological), KU70 (1:500;
mouse; sc-17789; Santa Cruz Biotechnology, Inc.), KU80 (1:500; rabbit; C48E7; Cell
Signaling Technology), BRCA1 (1:500; mouse; sc-6954; Santa Cruz Biotechnology,
Inc.), BRCA2 (1:500; mouse; sc-293185; Santa Cruz Biotechnology, Inc.), cGAS (1:500;
rabbit; D1D3G; Cell Signaling Technology). Finally, after 90 min incubation in
secondary antibodies (1:500; donkey anti-mouse, -goat, or -rabbit; Thermo Fisher
Scientific), the cells’ nuclei were stained with 8 µM Hoechst 33342 (Thermo Fisher
Scientific) for 15 min. When used, 1 µg/ml phalloidin-TRITC (MilliporeSigma) was
added to cells for 45 min just before Hoechst staining
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Immunoblotting
Western blotting was performed using standard methods. In brief, cells were briefly
trypsinized, washed 3x with cold PBS, and then lysed in RIPA buffer (150 mM NaCl, 1%
NP-40 alternative, 0.5% sodium deoxycholate, 0.1% SDS, 40 mM Tris pH 8.0) RIPA
buffer containing 1x protease inhibitor cocktail (Sigma, Catalog no. P8340) , and boiled
in 1x NuPage LDS sample buffer (Invitrogen, Catalog no. NP0007) with 2.5% v/v βmercaptoethanol. Approximately 1.0 ✕ 106 cells were used for each analysis. Proteins were
separated by electrophoresis in NuPAGE 4-12% Bis-Tris gels run with 1X MOPS buffer
(Invitrogen, Catalog no. NP0323) and transferred to an iBlot nitrocellulose membrane
(Invitrogen, Catalog no. IB301002). The membranes were cut into strips corresponding to
one lane loaded with lysate and one lane loaded with a molecular weight marker and then
blocked with 5% nonfat milk in Tris buffered saline (TBS) plus Tween-20 (TBST) for
1h.The membranes were washed with TBST and incubated with 1:500 secondary antibody
conjugated with horseradish peroxidase in 5% milk in TBST for 1 h at room temperature
with agitation. The membranes were washed again with TBST, then TBS, and developed
with a 3,3’,5,5’-teramethylbenzidine (TMB) substrate (Genscript L0022V or Sigma
T0565). Developed membranes were scanned and analyzed with ImageJ (National
Institutes of Health).
Transfection in U2OS cells
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All siRNAs used in this study were purchased from GE Healthcare (ON-TAR GETplus
SMA RTpool siBRCA1 L-003461-00, 5′-CAA CAU GCC CAC AGA UCAA-3′, 5′CCA AAG CGA GCA AGA GAAU-3′, 5′-UGA UAA AGC UCC AGC AGGA-3′,
and 5′-GAA GGA GCU UUC AUC AUUC-3′; siKU80 L-010491-00, 5′GCA UGG AUG UGA UUC AACA-3′, 5′-CGA GUA ACC AGC UCA UAAA-3′,
5′-GAG CAG CGC UUU AAC AACU-3′, and 5′AAA CUU CCG UGU UCU AGUG-3′; siLMNA L-004978-00, 5′GAA GGA GGG UGA CCU GAUA-3′, 5′-UCA CAG CAC GCA CGC ACUA-3′,
5′-UGA AAG CGC GCA AUA CCAA-3′, and 5′-CGU
GUG CGC UCG CUG GAAA-3′; and nontargeting siRNA D-001810-10, 5′UGG UUU ACA UGU CGA CUAA-3′, 5′-UGG UUU ACA UGU UGU GUGA-3′,
5′-UGG UUU ACA UGU UUU CUGA-3′, and 5′-UGG UUU
ACA UGU UUU CCUA-3′), except for si53BP1 (5′-UAU UAC CGU CUC
CUC GUUC-3′), which was a gift from R. Greenberg (University of Pennsylvania,
Philadelphia, PA; Tang et al., 2013). We do not distinguish between lamin A and lamin C
because mice seem equally viable expressing either lamin A or lamin C (Fong et al.,
2006; Coffinier et al., 2010). GFP-BRCA1 (71116; Addgene) was a gift from D.
Durocher (Lunenfeld-Tanenbaum Research Institute, Toronto, Canada); GFP-LBR was a
gift from R.-H. Chen (Academia Sinica, Taipei, Taiwan); GFP-KU70 and GFP-KU80
were gifts from S.L. Rulten (University of Sussex, Brighton, UK; Grundy et al., 2013);
and GFP-53BP1 and mCherry-cGAS were gifts from R. Greenberg (Harding et al.,
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2017). GFP-LMNA (Swift et al., 2013), GFP-MIIA, GFP-MIIB, and GFP-MIIA-Y278F
were all used in our prior research (Shin et al., 2011). Cells were passaged 24 h before
transfection. A complex of siRNA oligonucleotides (25 nM) or GFPs (0.2–0.5 ng/ml) and
1 µg/ml Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific) was prepared
according to the manufacturers’ instructions and then added for 3 d (siRNAs) or 24 h
(GFPs) to cells in corresponding media supplemented with 10% FBS. GFP-3 repair
factors consists of GFP-KU70, GFP-KU80, and GFP-BRCA1 (0.2–0.5 ng/ml each). All
plasmids are confirmed to produce specific functional proteins by Western blotting or
immunofluorescence. Knockdown or overexpression efficiency was determined by
immunoblotting or immunofluorescence following standard methods.
GFP-3 rescue experiment
U2OS siLMNA cells were plated on rigid plastic and cultured overnight, and then they
were transfected with either GFP-3 (consisting of GFP-KU70, GFP-KU80, and GFPBRCA1) or GFP-53BP1. A third Ctl sample was not transfected; we refer to these cells as
nontreated (NT). After a 24-h transfection period, all cells were fixed and
immunostained for γH2AX, and the NT sample was additionally immunostained for
KU80. Cytoplasmic GFP signal (or KU80 signal in the NT case) was used to identify
ruptured nuclei. Foci of γH2AX were counted for ruptured and nonruptured nuclei in all
three samples.
Alkaline comet assay
40

2.5 Materials and methods

The assay was performed according to manufacturer instructions (Cell Biolabs). First,
cells were detached, mixed with liquefied agarose at 37°C, deposited on a specially
treated glass slide, and dried for 15 min at 4°C. Next, the glass slide, containing cells in
agarose gel, was incubated in lysis buffer for 45 min and alkaline solution for 30 min.
Electrophoresis was conducted at 300 mA for 30 min, and then the slide was washed with
70% ethanol and air dried overnight. Finally, DNA dye was applied for 15 min, and
epifluorescence images were taken as described above.
Single-nucleotide polymorphism arrays & analysis
Genomic DNA was isolated from a minimum of 3.0 ✕ 105 cells with the Blood & Cell
Culture DNA Mini Kit (Qiagen, Catalog no. 13323) per the manufacturer’s instructions. In
the event that cells were either very rare (such as reporter-negative cells) or had poor
viability after FACS enrichment (specifically, iPSCs), genomic DNA was amplified postextraction using the Illustra Single Cell GenomiPhi DNA Amplification Kit (GE
Healthcare Biosciences, Catalog no. 29108107) following the manufacturer’s instructions.
All DNA samples were sent to The Center for Applied Genomics Core in The Children’s
Hospital of Philadelphia, PA, for Single Nucleotide Polymorphism (SNP) array
HumanOmniExpress-24 BeadChip Kit (Illumina). For this array, >700,000 probes have an
average inter-probe distance of ~4kb along the entire genome. For each sample, the
Genomics Core provided the data in the form of GenomeStudio files (Illumina).
Chromosome copy number and LOH regions were analyzed in GenomeStudio by using
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cnvPartition plug-in (Illumina). Regions with one chromosome copy number are not
associated with LOH by Illumina’s algorithm. Hence, regions with one chromosome copy
number as given by the GenomeStudio are added to the LOH region lists. SNP array
experiments also provide genotype data, which was used to give Single Nucleotide
Variation (SNV) data. In order to increase the confidence of LOH data given by the
GenomeStudio, the changes in LOH of each chromosome from each sample were cross
referenced to their corresponding SNV data. After extracting data from GenomeStudio, all
data analysis was done on Matlab.
Statistical Analysis
All statistical analyses were performed using Excel (2013; Microsoft).Unless otherwise
noted, statistical comparisons were made by unpaired two-tailed Student’s t tests. Unless
mentioned, all plots show MEAN ± SEM. n indicates the number of samples, cells, wells,
etc. quantified in each experiment.
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Chapter 3
Live cell chromosome loss reporter system
Fig. 3.1 has been recorded in Live cell monitoring for factors affecting genome variation, Biorxiv, 2018,
by Xia, Y., Zhu, K., Irianto, J., Andrechak, J.C., Dooling, L.J., Pfeifer, C.R., Discher, D.E.. Fig. 3.1 A was
drawn by Dr. Yuntao Xia; all cancer cell line (A549, U2OS, H23) gene editing tag fluorescent
chromosome except for A549-RFPLMNB1, and some treatments and flow cytometry in Fig. 3.3
were conducted by Brandon Hayes. Dr. Jerome Irianto developed the code for SNPa in Fig. 3.2.
Kuangzheng Zhu conducted imaging of Fig. 3.1 B, validated all reporters, and conducted some
treatments and flow cytometry in Fig. 3.3.
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3.1 Design and validation of reporter
To visualize loss of a chromosome and address possible external causes in live
circumstances, especially biophysical in this study, as well as viability and heritability, a
candidate constitutive gene on one copy of any chosen chromosome (monoallelic) is first
gene-edited (with CRISPR or Zinc Finger) as a fluorescence protein fusion (Fig.3.1A). A
constitutive gene expresses protein that isn’t silenced epigenetically or is expressed at
different levels in different stages of cell cycle. In other words, it expresses the target
protein all the time within a cell. Normal regulation of expression can help avoid epigenetic
silencing of a gene, and proper protein localization helps maintain normal physiology while
avoiding confusion with autofluorescence. Subsequent loss of fluorescence that occurs
spontaneously or by various chemical or mechanical perturbations can be tracked by single
cell expansion (Fig.3.1B) or flow cytometry for reporter-negative cells, and a constitutive
gene is positively identified when allele loss is documented by methods including genome
array-based methods and single cell sequencing, as well as proved with traditional
techniques such as karyotyping and PCR which, however, involve cell denaturation
(Fig.3.2 A, Fig. C1).
Many non-constitutive genes with their proteins are tested, such as histone-H2B
(Chr-6) and beta-CTNNB1 (Chr-3, Fig. 3.2 B, Fig.C3). These genes do not show
chromosome loss in fluorescence-negative populations and therefore are not candidates for
the reporters. Moreover, selective growth of pre-existing subpopulations rather than
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A

B

Figure 3.1: Concept of Chr-loss cell reporter. (A) Live cell chromosome reporter concept,
which requires identifying alleles that are constitutively expressed even when fused to GFP or
RFP. (B) RFP-positive and RFP-negative A549 colonies using the Chr-5 reporter in which one
allele of LMNB1 has an N-terminal RFP. A549 cells were sorted to purity via FACS, plated
sparsely, and allowed to grow for a week. Scale bar = 100 µm.

de novo genetic or epigenetic change is always a concern in studies of rare cells, with initial
kinetics being key to mechanism.
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A
Figure 3.2: SNPa
validation
on
Chr-loss
reporters.
(A)
Bulk DNA from
sorted reporter-pos
and -neg cells was
analyzed on single
nucleotide
polymorphism
arrays
(SNPa),
with differences
shown
and
independently
duplicated
for
normal
diploid
induced
pluripotent stem
cells (iPSCs) and
hypotriploid A549
lung
adenocarcinoma
cells. Loss of
Heterozygosity
(LOH) is indicated
in purple.

B

(B) Chr reporter
designs tried for
various loci and
cell lines. Nonconstitutive loci
show fluorescence
loss but fail to
show chromosome
loss in genetic
analyses..
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Even a first set of images after a fresh sort of RFP-pos cells showed similar sized
colonies of RFP-neg and RFP-pos cells (Fig.3.1B, C1), consistent with natural,
spontaneous creation of genetically distinct cells.

Figure 3.3: MPS1i validation of Chr-loss reporter system. Chr reporter-neg cells for all engineered lines
with reporters (iPSCs, A549, H23 lung adenocarcinoma, and U2OS osteosarcoma) treated with MPS1i or
DMSO control for 3 days. n = 3 replicates per condition; unpaired two-tailed t-test with Welch’s correction
between each MPS1i-treated and its corresponding DMSO control. *p < 0.05, **p < 0.005, ***p < 0.0005,
****p < 0.0001.
with Brandon Hayes

One

or

more

constitutive

genes

were

consistently

identified

on

Chromosomes (Chr) 5, 9, 12, and 19 as well as dual-tagged combinations (Fig.3.2, C2,
C4), and double chromosome loss from fluorescence-double negative cells are detected
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and verified (Fig.3.2, C4), which indicates the multiplexity and universality of the system.
MPS1 inhibitor reversine is known to lead to genomic instability by increasing
chromosome mis-segregations during mitosis when spindle assembly checkpoint is
bypassed. After treatment of the inhibitor, reporter cells show gigantic increase in reporterneg% (Fig. 3.3), further confirming that the reporter evaluates the degree of chromosome
loss.

3.2 Discussion

Based on the CRISPR/Cas9 gene editing methodology (Fig. 3.1, 3.2, C1, C2), live
cell chromosome-loss reporter system is ubiquitously applicable on all cells and
chromosomes. The current well-established non-overlapping fluorescence wavelengths of
microscope and flow cytometry generally allow 4 channels with different colors (BFP,
GFP/YFP, RFP, far-red) (Cossarizza et al., 2017; Lin et al., 2015), for which, theoretically,
a maximum of 4 non-homologous chromosomes can be engineered using the reporter
system given its multiplexity. Since human cells have 22 non-homologous autosomes, 4
chromosomes can cover one fourth of the genome, providing a giant range of studying
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genomic variation in cancer or normal cell lines. Any perturbations, including chemical
and physical, described above, can be applied to reporter cells with a readout as to how
many fluorescence-neg individuals occur as a result. In this case, thousands of black-box
assays can be performed with the reporter cells exposed to a series of chemicals, siRNAs,
and physical conditions, respectively, to find out their reporter-neg% compared to
corresponding control groups. In the end, interesting results can then be traced back to
discover the mechanisms hidden within black boxes. For instance, if a chemotherapy drug,
when applied on Chr-9 reporter A549 cell, shows an increase in reporter-neg%, this
indicates the drug favors production of Chr-9 loss cells which somehow resist to the drug
and can continue to grow. Multiplexed reporter cells, on the other hand, can present the
increase and decrease in many chromosomal losses, and provide a broader general picture
of genomic variation on the perturbations applied.

Nevertheless, gain of chromosomes tagged with constitutive genes expressing
fluorescence cannot be accurately pinpointed, traced, and isolated with this system. The
loss of fluorescent protein signal introduces a cell without nuclear or cytoplasmic signal
under microscope, or a cell with multiple orders of magnitude lower signal compared to
reporter-positives in flow cytometer, because fluorescent protein is no longer expressed as
a result of the loss of a chromosome carrying its gene. Obtaining a reporter chromosome
from abnormal mitosis doesn’t necessarily translate to a double fluorescence signal,
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because protein expression is positively correlated with gene dosage but isn’t completely
proportional to it (Alberts, 2015). If a certain protein is saturated, increased protein
expression can terminate. Even if two alleles of reporter do mean twice the amount of
fluorescence protein signal, flow cytometry cannot distinguish the fold change of 2 which
falls within the range of noise native to the machine and cell cycle. Therefore, the reporter
has limitations in studying chromosome gains. Moreover, since mis-aligned lagging
chromosomes usually end up in micronuclei with their genetic materials degraded (Zhang
et al., 2015; Liu et al., 2018), loss instead of gain of chromosomes more importantly depicts
the CNV after errors in mitosis.

In recent years, it has become popular to directly tag chromosomes with a focal
fluorescence signal using the CRISPR/Cas method. Unlike our chromosome loss reporter
which reflects the existence of chromosome by the fluorescence carried on the expressed
protein, this life-FISH technique lightens the chromosome by itself by complementary base
pairing to a sequence with hundreds of nucleotides in the chromosome of interest (Wang
et al., 2019; Chen et al., 2020; Ma et al., 2015). Such method has been used prevalently in
live cell imaging and chromatin localization/mapping. It isn’t difficult to perceive that cells
losing the tagged chromosome(s) can be easily identified by high-throughput imaging and
would show absolutely zero focal signal, since no lagging period resulting from protein
degradation would exist. However, the single focal signal instead of widespread
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nucleoplasmic or cytoplasmic signal prevents negative cells from being distinguished from
positive cells when flow cytometry is applied, due to the lack of signal in order-ofmagnitudes of the former. Therefore, separation of the cells using flow cytometry sorting---one of the most efficient methods for separating cells based on morphology, size, and
fluorescence----fails to work. Provided that imaging sample collection covers much lower
sample space than the capacity of flow cytometry, our reporter system based on protein
expression, which can be functional under both flow cytometry and fluorescence imaging,
exhibits its advantage here.

3.3 Materials and methods
Cell lines and tissue culture
The following cancer cell lines for this study were: A549 lung adenocarcinoma, U2OS
osteosarcoma, and NCI-H23 lung adenocarcinoma (referred to as H23 in text). The A549
and U2OS cell lines were obtained from the American Type Culture Collection (ATCC).
The H23 cell line was a kind gift from Dr. Michael C. Bassik (Stanford University). A549
cells were cultured in Ham’s F-12 media (Gibco 11765047); U2OS cells in DMEM (Gibco,
Catalog no. 10569010); and H23 cells in RPMI 1640 (Gibco, Catalog no. 11879020). The
original A549 RFP-LMNB1 cell line was engineered by Sigma-Aldrich. HEK293T cells
used, acquired from ATCC, for lentiviral packaging were also cultured in DMEM. All
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aforementioned cell lines were cultured in media supplemented with 10% (v/v) fetal bovine
serum (FBS; MilliporeSigma, Catalog no. F2442) and 100 U ml -1 penicillin-streptomycin
(Gibco, Catalog no. 15140122). All cells were passaged every 2-3 days using 0.05%
Trypsin/EDTA (Gibco, Catalog no. 25300054). All cell lines were incubated at 37 oC and
maintained at 5% CO2.

The following induced pluripotent stem cell (iPSC) lines were also used, all of
which were acquired from the Coriell Institute for Biomedical Research and
generated/validated by the Allen Institute for Cell Science: iPSC GFP-LMNB1 (AICS0013 cl.210), iPSC RFP-LMNB1 GFP-SEC61B (AICS-0059 cl.36), and iPSC FBL-GFP
NPM1-RFP (AICS-0084 cl.18). iPSCs were cultured in mTseR Plus medium (STEMCELL
Technologies, Catalog no. 05825), with mTser Plus 5X supplement and 100 U ml -1
penicillin-streptomycin. For passaging and maintenance of iPSCs, cells were lifted with
accutase (Sigma, Catalog no. A6964) at 37oC and re-plated into 10-cm plates (Corning)
coated with Matrigel (Corning, Catalog no. 356231) following the Allen Institute of Cell
Science’s protocol. 10 mM ROCK inhibitor (Y-27632; STEMCELL Technologies,
Catalog no. 72302) was added to replated cultures to help with adherence and to prevent
differentiation. Passaging was done once iPSC cultures reached 70% confluency to prevent
spontaneous differentiation. All iPSC lines were also cultured at 37oC and maintained at
5% CO2.
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Monoallelic chromosome tagging
For all attempted monoallelic chromosome reporters as described in Fig. 1E, all donor
constructs were a gift from Allen Institute of Cell Science: AICSDP-8:TOMM20-mEGFP
(Addgene plasmid #87423; http://n2t.net/addgene:87423;

RRID:Addgene_87423),

AICSDP-13:FBL-mEGFP (Addgene plasmid #87427; http://n2t.net/addgene:87427;
RRID:Addgene_87427), AICSDP-35:AAVS1-mEGFP (Addgene plasmid #91565;
http://n2t.net/addgene:91565; RRID:Addgene_91565), AICSDP-42:AAVS1-mTagRFPTCAAX

(Addgene

plasmid

RRID:Addgene_107580),
http://n2t.net/addgene:87420;
(Addgene plasmid
AICSDP-52:

#107580;

AICSDP-1:PXN-EGFP

http://n2t.net/addgene:107580;
(Addgene

RRID:Addgene_87420),

(Addgene

#87420;

AICSDP-10:LMNB1-mEGFP

#87422; http://n2t.net/addgene:87422;

HIST1H2BJ-mEGFP

plasmid

RRID:Addgene_87422),
plasmid

#109121;

http://n2t.net/addgene:109121 ; RRID:Addgene_109121), AICSDP-7:SEC61B-mEGFP
(Addgene plasmid # 87426; http://n2t.net/addgene:87426; RRID:Addgene_87426).

All knock-in reporter lines were generated following the protocol established in (1)
using CRISPR/Cas9 technology. Donor plasmids were designed such that unique designs
for each target locus contain 5’ and 3’ homology arms (1 kb each) for the desired insertion
site, based on the GRCh38 reference human genome. For editing, we use the ribonucleic
protein (RNP) method with recombinant wild type S. pyogenes Cas9 protein precomplexed with a synthetic CRISPR RNA (crRNA) and a trans-activating crRNA
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(tracrRNA) duplex. Recombinant wild-type Cas9 protein was purchased from the
University of California–Berkeley QB3 Macrolab, while crRNA and tracrRNA
oligonucleotides were designed by and purchased from Horizon Discovery. For
transfection of donor templates into target cells, we used the electroporation using a Gene
Pulser Xcell Electroporation System (Bio-Rad). 700,000 targets cells were lifted using
0.05% Trypsin/EDTA, resuspended in 200 ul of fresh media without penicillinstreptomycin, and loaded into a 0.4-cm cuvette. 4 µL of both 10 µM crRNA:tracrRNA
duplex and 10 µM recombinant Cas9 protein were added to the cell solution, as well as 8
µg of donor plasmid. Electroporation conditions were as follows: (1) A549 and H23: 200V
with 45 ms pulse length using a square-wave protocol; (2) U2OS: 160V with 30 ms pulse
length using a square-wave protocol. After electroporation, cells were allowed to expand
for ~1 week and then enriched via fluorescence-activated cell sorting (FACS), as described
below. 3-5 FACS enrichment cycles were performed to achieve a pure reporter-positive
population.

Single-cell CNV-sequencing and analysis.
A549 cells from RFP-pos clone-3, RFP-neg clone-1 and RFP-neg clone-2 were plated in a
24 well plate at 60,000 cells per well and cultured for 2 days. RFP-pos clone-3 was used
as the reporter-positive sample, and a 1:1 mixture of the two reporter-negative clones
served as the overall reporter-negative sample. The DNA library was constructed using the
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Chromium Single Cell CNV kit from 10X Genomics (Catalog no. PN-1000041; PN1000057; PN-1000032; PN-1000036, Pleasanton, CA) per the manufacturer’s instructions.
The libraries were submitted to the University of Pennsylvania’s Next Generation
Sequencing Core (12-160, Translational Research Center, University of Pennsylvania) for
sequencing using HiSeq 4000, 150 bp paired-end from Illumina (San Diego, CA). For each
sample, the copy number data was generated using Cell Ranger DNA pipeline (10X
Genomics) and was visualized using Loupe scDNA Browser (10X Genomics). The data
were then exported to Python to remove the noise. Cells that were flagged as “noisy” by
the Cell Ranger pipeline were removed from further analysis. Cells with more than 69
copies of chromosomes were removed from the CNV analysis to avoid potential influence
of cell cycle effects. Built-in hierarchical clustering from 10X Genomics was also used to
rearrange the cells.

Cell type annotations
Raw expression matrices were used as the input for the singleR (1.4.1) package (Aran et
al., 2019). The cell types were annotated based on Human Primary Cell Atlas (Mabbott et
al., 2013).

Karyotyping
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Cells used for karyotyping were plated in T25 flasks (Corning), cultured for 2-3 days to
reach ~50% confluency. The media was then discarded and replaced with fresh media to
fill the entire flask with a closed lid, after which the flask was wrapped with parafilm. The
samples were then sent to Cell Characterization Services for metaphase-spread
karyotyping.

Polymerase chain reaction (PCR) for reporter validation
DNA was extracted as previously described for SNP arrays. The isolated DNA was then
mixed with materials from KAPA HiFi PCR Kit (Roche, Catalog no. 07958838001) to start
each PCR reaction. Each reaction contains 5 µL 5X HiFi Fidelity Buffer, 0.75 µL 10 mM
KAPA dNTP Mix, 0.5 µL 1U/µL KAPA HiFi DNA Polymerase, 0.75µL of 10 µM forward
and reverse primers, respectively, and 1 ng of extracted DNA template. PCR grade water
was then filled up to 25µL. All materials suggested by the kit were placed on ice prior to
mixing. The reaction mix was placed on the thermocycler with the following temperature
cycling protocol: Initial denaturation at 95oC for 3 min; 35 cycles of denaturation at 98oC
for 20 sec, annealing at 65oC for 15 sec, extension at 72oC for 60 sec/kb; and final extension
at 72oC for 1 min. All PCR products were then run on a 1% (v/v) agarose (Invitrogen,
Catalog no. 16500500) gel at 100V for 1h and then imaged using a ChemiDoc MP Imaging
System (Bio-Rad, Catalog no. 17001402).

Reporter validation via single-nucleotide polymorphism arrays & analysis
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Genomic DNA was isolated from a minimum of 3.0 ✕ 105 cells with the Blood & Cell
Culture DNA Mini Kit (Qiagen, Catalog no. 13323) per the manufacturer’s instructions. In
the event that cells were either very rare (such as reporter-negative cells) or had poor
viability after FACS enrichment (specifically, iPSCs), genomic DNA was amplified postextraction using the Illustra Single Cell GenomiPhi DNA Amplification Kit (GE
Healthcare Biosciences, Catalog no. 29108107) following the manufacturer’s instructions.
All DNA samples were sent to The Center for Applied Genomics Core in The Children’s
Hospital of Philadelphia, PA, for Single Nucleotide Polymorphism (SNP) array
HumanOmniExpress-24 BeadChip Kit (Illumina). For this array, >700,000 probes have an
average inter-probe distance of ~4kb along the entire genome. For each sample, the
Genomics Core provided the data in the form of GenomeStudio files (Illumina).
Chromosome copy number and LOH regions were analyzed in GenomeStudio by using
cnvPartition plug-in (Illumina). Regions with one chromosome copy number are not
associated with LOH by Illumina’s algorithm. Hence, regions with one chromosome copy
number as given by the GenomeStudio are added to the LOH region lists. SNP array
experiments also provide genotype data, which was used to give Single Nucleotide
Variation (SNV) data. In order to increase the confidence of LOH data given by the
GenomeStudio, the changes in LOH of each chromosome from each sample were cross
referenced to their corresponding SNV data. After extracting data from GenomeStudio, all
data analysis was done on Matlab.
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Flow cytometry and FACS
All flow cytometry was performed on a BD LSRII (Benton Dickinson) and analyzed with
FCS Express 7 software (De Novo Software). All studied cell lines were detached by brief
trypsinization (for all cancer lines in 2D culture) or with accutase (for iPSCs), washed, and
resuspended in FACS buffer (PBS + 5% FBS) with 1.0 µg ml -1 DAPI (MilliporeSigma,
Catalog no. 09542). For fluorescence-activated cells sorting, or FACS, cells were prepared
in the same way as described above except that freshly prepared sterile FACS buffer was
used and no DAPI was included. FACS was performed on either a BD FACS Aria II or a
BD FACS Jazz. Prior to any assay that assessed reporter-negative subpopulation
generation, cells were FACS-enriched for only reporter-positive cells.

For gating, forward scatter parameters FSC-A vs. FSC-H and side scatter
parameters SSC-A vs. SSC-H were used to remove aggregates from analysis. Live cells
were gated on using forward scatter and side scatter (FSC-A vs. SSC-A). DAPI was further
used to discriminate between live cells and debris/dead cells.

Treatment
For all cancer cell treatments, either 300,000 cells were plated per well in a 6-well plate
(Corning) or 60,000 cells per well in a 24-well plate (Corning). For iPSC treatments,
60,000 cells were plated per 6-well plate. MPS1 inhibitor reversine (Cayman Chemical,
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Catalog no. 10004412) and dimethyl sulfoxide (DMSO; Millipore Sigma, Catalog no.
D2438) were used for treatment. The reversine concentrations and treatment times used,
unless otherwise stated, are: for A549, 0.1 µM for 72h; for U2OS and H23, 1.5 µM for 24h
followed by washout and 48h recovery; for iPSCs, 0.25 µM for 24h followed by washout
and 24-48h recovery.

Immunoblotting
Western blotting was performed using standard methods. In brief, cells were briefly
trypsinized, washed 3x with cold PBS, and then lysed in RIPA buffer (150 mM NaCl, 1%
NP-40 alternative, 0.5% sodium deoxycholate, 0.1% SDS, 40 mM Tris pH 8.0). RIPA
buffer also contained 1X protease inhibitor cocktail (Millipore Sigma, Catalog no. P8340).
After lysis, centrifugation was done to discard lipids and other contaminants. Samples were
then boiled in 1X NuPage LDS sample buffer (Invitrogen, Catalog no. NP0007) with 2.5%
v/v β-mercaptoethanol. Approximately 1.0 ✕ 106 cells were used for each analysis.
Proteins were separated by electrophoresis on NuPAGE 4-12% Bis-Tris gels run with 1X
MOPS buffer (Invitrogen, Catalog no. NP0323) and transferred to an iBlot nitrocellulose
membrane (Invitrogen, Catalog no. IB301002). The membranes were cut into strips
corresponding to one lane loaded with lysate and one lane loaded with a molecular weight
marker and then blocked with 5% nonfat milk in Tris buffered saline (TBS) plus Tween20 (TBST) for 1h. The membranes were washed with TBST and incubated with 1:1000
primary antibody (anti-LMNB1 (Abcam, Catalog no. ab16048), anti-beta-actin (santa
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Cruz, Catalog no. sc-47778) overnight.The membranes were washed with TBST and
incubated with 1:2000 secondary antibody conjugated with horseradish peroxidase in 5%
milk in TBST for 1 h at room temperature with agitation. The membranes were washed
again with TBST, then TBS, and developed with a 3,3’,5,5’-tetramethylbenzidine (TMB)
substrate (Genscript L0022V or Sigma T0565). Developed membranes were scanned and
analyzed with ImageJ (National Institutes of Health).

Imaging
Epifluorescence imaging was performed using an Olympus IX71 with a digital camera
(Photometrics) and a 20x/0.4 NA objective.

Data reporting
Statistical methods were not used to predetermine sample size. The experiments were not
randomized. Investigators were not blinded to allocation during experiments and outcome
assessment.

Statistics and reproducibility
The statistical methods for each experiment are included in the corresponding Figure
legends. All statistical analyses were done on GraphPad Prism 9.0. All experiments were
biologically repeated and confirmed. Unless otherwise mentioned, all plots show MEAN±
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SEM, and statistical comparisons are considered significant if p<0.05. n indicates the
number of samples, cells, wells, etc. quantified in each experiment. Additionally, at least
two separate investigators performed each experiment separately for reproducibility.
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Chapter 4
Mitosis under confinement leads to
viable and heritable descendants,
results from mechanically triggered
MT mis-attachment, and is protected
by Myosin II
Fig. 4.1, 4.8 F were designed by Dr. Dennis Discher and drawn by Brandon Hayes. Brandon
Hayes conducted some analyses and flow cytometry for Fig. 4.4 A, performed some
confinement assays in Fig. 4.4 C-D, conducted experiments for MPS1i treatment in Fig. 4.5,
analyzed Chr-5 reporters in Fig. 4.7 C, contributed half to Fig. 4.10 A, and performed
confinement assays for Fig. 4.10 D; Mai Wang contributed some replicated data to Fig. 4.4 A,
and performed RNA sequencing in Fig. 4.9 A. Junhong Du performed some confinement
assays in Fig. 4.4 C-D, analyzed Chr-9 reporters in Fig. 4.7 C; Kuangzheng Zhu conducted Fig.
4.2, 4.3, 4.6, 4.8, Fig.4.4 B, 4.5 A-B, 4.7 A-B, 4.9 B-D, 4.10 B-C, conducted some analyses
and flow cytometry for Fig. 4.4 A, performed some confinement assay in Fig. 4.4 C-D, did all
data fitting in Fig. 4.5, analyzed Chr-19 reporters in Fig. 4.7 C, prepared cells for Fig. 4.9 A,
contributed half to Fig. 4.10 A, performed control experiments for Fig. 4.10 D.
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4.1 Introduction

Mechanical aspects of a cell’s microenvironment such as matrix stiffness and 3D
rigid confinement can exert diverse effects on a cell in mitosis as well as interphase,
including changes in cell shape and key cytoskeletal and nuclear structures (Uhler and
Shivashankar, 2017; Nava et al., 2020; Przybyla et al., 2016; Paszek et al., 2014; Segel et
al., 2019; Meng et al., 2018; Engler et al., 2006;Petridou et al., 2021). Normal tissue cells
nonetheless seem to show genetic differences within the same person (Yizhak et al., 2019),
and such variation across different tissues positively correlates with microenvironment
stiffness E of each tissue (Swift et al., 2013; Pfeifer et al., 2017). In our previous studies
(Chapter 2, Irianto et al., 2017), we showed that constricted migration, as mimicking the
environment of extracellular matrix in stiff tissues, causes nuclear envelope rupture and
repair factor mislocalization, yielding DNA damage. However, chromosome gains or
losses (Δ) contribute to cancer variation even more than point mutations in DNA. A recent
study of medulloblastoma, for example, shows that the most frequently detected mutation
(in MYC) occurs in only 17% of patients whereas every one of more than a dozen copy
number changes occur in more than 30% of patients (Northcott et al., 2017). In clinical
trials by Yamanaka and colleagues on two aged patients (>65 yrs), induced pluripotent
stem (iPS) cells generated from one of the patients exhibited copy number variations that
prevented their use for fear of carcinogenesis (Mandai et al., 2017). Such trends motivate
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the hypothesis that mitosis within rigidly confining 3D microenvironments favors heritable
mechanogenetic changes.

Mechanical contributions to changes in a cell’s DNA sequence seem reasonable
to infer from recent studies of myosin-II, which is key to animal cell mechanosensing of
microenvironments (Parajón et al., 2021;Stewart et al., 2011; Sedzinski et al., 2011;
Rancati et al., 2008) and to driving mitotic rounding (Ramanathan et al., 2015). In yeast
and non-adherent cells, myosin-II also drives cytokinesis, and deletion of myosin-II
somehow leads to multiple chromosomal gains and losses in viable yeast (Rancati et al.,
2008), which indicates that myosin-IIA protects the genome. Interestingly, mouse
knockdowns of nonmuscle myosin-IIA within dense 3D tissues such as skin induces
squamous cell carcinoma in embryos (Schramek et al., 2014; Conti et al., 2015), and
since most cancers typically involve multiple genetic changes (Davoli et al., 2013;
Tomasetti and Vogelstein, 2015), myosin-IIA knockdown could be a key initiator that
couples to microenvironment. Indeed, while a rigid cell wall shelters yeast from
mechanical stresses and microenvironments, abnormal 3D tissue architectures have been
observed with mouse and human cells to enhance chromosome mis-segregation (Knouse
et al., 2018). For an isolated mitotic animal cell, strong compression between two rigid
surfaces distorts the mitotic spindle and increases mis-segregation relative to standard 2D
cultures - but such squashing also kills cells (Dumont and Mitchison, 2009; Lancaster et
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al., 2013). Whether 3D microenvironments including rigid confinement can exert
heritable mechanogenetic effects is thus unclear.

To address such issues, we first identify GFP/RFP tagged genes that are suitable
as live-cell reporters. Visualizing an individual cell before, during, and after a genetic
change can provide key evidence of viability and heritability that is at best inferred from
sequencing approaches which require cells to be killed for nucleic acid extraction----as
conducted in our previous studies (Fig. 2.8). Rare changes (e.g. ~0.1 to 1% of cells) are
also a challenge for sequencing, in part because of error rates (Yizhak et al., 2019), but an
initially rare change is the causal origin for any sub-population of viable, non-senescent
cells that emerges via subsequent selection and competitive expansion. For a normal cell
type, we focus on induced Pluripotent Stem cells (iPSC’s) as a model stem cell relevant
both to tumor and tissue stem cells and to major concerns over Chr instability in
pluripotent cells (Mandai et al., 2017; Skamagki et al., 2017). We also study several solid
tumor derived lines (A549 and H23 lung adenocarcinomas, and U2OS osteosarcoma).
Heritable changes are ultimately shown in live viable cells to be a genuinely genetic form
of mechanotransduction from stiff 3D microenvironments, with a surprisingly diminished
role for a mitotic checkpoint but significant contributions from chromosome compaction
and actomyosin.
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4.2 Confined mitosis causes chromosome loss

Confined mitosis lengthens the MT spindle and increases abnormal divisions
relative to mitotic rounding in standard 2D cultures (Dumont and Mitchison, 2009;
Lancaster et al., 2013; Cadart et al., 2014), but applied confinement can also kill many cells
(Fig.4.1, 4.2, D4). Viability of cells that have lost or gained Chr’s in confined mitosis has
thus been unclear and is of concern given the toxicity of pertinent drugs such as MPS1i.
Physiological relevance of confined mitosis has also been unclear, and so mitotic cells in
human-in-mouse xenografts were 3D-imaged by confocal microscopy. Mitotic chromatin
and interphase nuclei show the same height in iPSC-derived teratomas and A549 tumors - unlike standard 2D cultures (Fig. 4.3). The teratomas have palpable rigidity similar to the
tumors, which are not only collagen rich and stiff (~5 kPa) (Swift et al., 2013).

To assess the in vitro effects of rigid confinement on Chr reporters in cells dividing
in culture, we applied a ring-weight on top of an upper glass coverslip after sparsely mixing
rigid polystyrene microbeads with the cells so as to limit the compression. Confinement
even for ~8h suffices to increase abnormal mitosis in terms of evident chromosome missegregation (Fig.4.3). Recovery in 2D culture for 16-48h was followed by flow cytometry
quantitation and also sorting to verify Chr-loss (Fig.4.4 C). Reporter loss of ~1% after
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Figure 4.1: Schematic of confinement on Chr-loss reporter cells. Mitotic perturbations
might affect Chr loss and/or viability: maximal rounding in 2D culture is suppressed when
cells are rigidly confined in vitro or surrounded in vivo by cells and matrix. Confinement is
capable of killing cells.

confined mitosis of iPSCs and A549s (for multiple Chr’s) proves quantitatively higher than
2D (Fig.4.4 C,D), and losses correlate with observed levels of abnormal mitosis (Fig.4.4
A,B). Loss of any one of the Chr reporters is far below abnormal mitosis frequencies (by
~15-fold for iPSCs and ~60-fold for A549s) which is consistent with numerous Chr’s being
lost. Because A549s divide every ~24h, cells were Noc-synchronized before confinement
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Figure 4.2: Confinement spacing optimization to minimize death. (A) Timeline of
Confinement Application for cell death tracking. (B) Confinement with 6.58μm spacer
beads requires longer time to cause mitotic cell death than with 2.16 μm spacer beads
and without spacer, and the former doesn’t cause as much death as the latter. So 6.58μm
spacer is the primary choice of spacers for our assays. Majority of cells start as mitotic
after nocodazole-induced synchronization. (C) Confinement without spacer beads leads
to large scale of mitotic cell death within 10 minutes. *p < 0.05, ~*p = 0.05. Scale bar
= 100 μm.
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A
Figure 4.3: Mitotic
nuclei in vivo or under
confinement exhibit
lower height than in
vitro control.
(A)
Images
of
chromatin and plots of
chromatin height in
iPSCs and A549 cells
in either standard 2D
culture,
rigidly
confined culture, or 3D
in vivo teratomas or
tumors engrafted at
subcutaneous sites in
immunodeficient mice.
All scale bars = 5 µm.

B

(B) Comparison among
mitotic and interphase
chromatin height in
standard 2D, rigidly
confined culture, or 3D
in
vivo
teratoma/tumors. Mean
and SEM (n = 3
replicates;
MannWhitney U-rank test:
**p < 0.005; ****p <
0.0001;
ns,
not
significant.
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A

B

C

D

Figure 4.4: Confinement leads to increase in mitotic abnormality and more reporterneg cells. (A) Flow cytometry measures of the percentage of Chr-5 reporter-neg cells
plotted against percentage of abnormal mitosis for A549s and iPSCs. (B) Images of
abnormal mitosis of A549 and iPSCs. Scale bar = 5 µm. (C)–(D) Flow cytometry analyses
of Chr-5 reporter loss in iPSCs and A549s in either confined or standard 2D cultures; (D)
(i) Noc-synchronized A549 cells with three different reporters, or (ii) two distinct iPSC
clones (but no synchronization because iPSCs double in ~10h, which is faster than A549s).
(Continued next page)
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Figure 4.4: (Previous page) (A) & (D): n = 3 replicates; unpaired two-tailed t-test with Welch’s correction:
*p < 0.05, **p < 0.005, ***p < 0.0005, ns, not significant.
A: with/Brandon Hayes, replicated by Mai Wang C: with Brandon Hayes D: with Brandon Hayes and
Junhong Du

in some studies － with small residual effects fitting the trend. Synchronization of iPSCs
was unnecessary because these cells double in ~10h, and while microscopy detection of
abnormal mitosis is useful, it does not predict Chr loss: some iPSCs show abnormal mitosis
without Chr reporter loss, but A549s show the opposite.

4.3 Chromosome loss in cells generated from confined mitosis
and MPS1 inhibition are viable and heritable

Formation of colonies and maintenance of proportion of reporter-neg cells within
the bulk population, which is higher in perturbed condition than basal level, both provide
evidence for viability and heritability (Fig.4.7 C). A549s in 2D culture show basal levels
of reporter-neg cells and colonies for the various Chr Reporters even after 2-3 wks, and 971
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Figure 4.5: (Previous page) Mathematical model shows confinement and MPS1i lead to
reporter-neg population surviving in long-term after perturbation withdrawal in A549 but not
iPSC. Chr-5 reporter-negative kinetics for A549s after repeated cycles of rigid confinement for 12
days and recovery in 2D culture (A), or MPSi treatment and recovery of A549s with multiple
reporters (C) or iPSCs (D). For the former, after 36 days, flow-sorted RFP-neg cells were plated
back sparsely at 1:1 mixture with RFP-pos cells (B); RFP-neg cell numbers in CFUs after 1 week
are the same, and the mixture also showed the same total cell numbers for all RFP-pos and -neg
sample conditions. (A)-(D): n = 3 replicates; unpaired two-tailed t-test with Welch’s correction
between each treatment condition at the same timepoint: *p < 0.05, **p < 0.005, ***p < 0.0005, ns,
not significant. Scale bar = 100 µm.
MPS1i-treated experimental result from Brandon Hayes

days of MPS1i not only tends to increase reporter loss and colony counts but drug
withdrawal also leads to variable levels of viable cells with sustained loss of all Chr
reporters (Fig.4.5 C). Likewise, for compression-generated reporter-negative A549s, once
the confinement cycles are stopped, a decay to a stable fraction of reporter-negative cells
greater than the controls is again observed (Fig.4.5 A). To again address possible concerns
over selection and expansion versus de novo genetic change, we sorted RFP-neg and RFPpos cells from confinement or control conditions, mixed 1:1 the neg: pos cells for either
condition, and cultured in 2D for 1 week. The same total number of RFP-neg cells and
RFP-pos cells were obtained from all conditions, with heritable loss of reporter evident in
equally large and viable colonies (Fig. 4.5 B). The results are not only consistent with de
novo genetic change but also with a similarity in mechanism between MT-disrupting
MPS1i and mitotic compression. Viable interphase A549s after confinement re-spread
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Figure 4.6: (Previous page) Modeling and scaling of MPS1i and confinement generating
stable reporter-neg populations. (A) Schematic Diagram of the model of chromosome loss
indicated by fluorescence loss. Cell division and fluorescence loss are both proportional to cell
density, with 𝐾𝑝 , 𝐾𝑛 , 𝑘𝑙 being net proliferation coefficient of positive cells, net proliferation
coefficient of negative cells, and fluorescence-loss coefficient, respectively. The Fluorescencenull cell proportion model is then derived to be a function of 𝑟 (𝑡). What’s shown in figure 2 is
100 𝑟 (𝑡), as is expressed as percentage. Derivation of the model is shown in supplementary
material D1. (B) Data fitting parameters are listed, as normalized to the fixed value 𝐾𝑝, 𝐷𝑀𝑆𝑂 ,
corresponding to fitting curves in Fig. 4.5. For each reporter, 𝑘𝑙, 𝑅𝑣, 𝑡𝑟𝑒𝑎𝑡 >> 𝑘𝑙, 𝐷𝑀𝑆𝑂, 𝑡𝑟𝑒𝑎𝑡 ,
consistent with the fact that MPS1 inhibition leads to increased chromosome loss.
Fitting is based on the following assumptions:
Because protein degradation doesn’t happen immediately after chromosome loss, the effect of
MPS1 inhibitor reversine as to pos-to-neg conversion is delayed until day 12 for Chr-5, 9,
19, and day 18 for Chr-12, while the drug is actually released at day 9.
For each reporter, 𝑘𝑙 for each phase is not necessarily the same, but ∆𝐾 is identical for all the
phases except for reversine-treat phase.
(C) Treatment phase of all reporters as well as Chr-5 reporter under confinement scale with
numers of divisions with power-law. In the plot, Chr-5 treated with DMSO/Reversine and
with/without confinement are displayed. Other reporters are not displayed in the plot but scaled
power law exponents (slope in log-scale) are presented. The perturbed processes have steeper
slope than its corresponding control, with a fold change ranging from 1.5 to 10.

their decondensed chromatin after exiting mitosis, re-assemble their lamina, and proliferate
normally (Fig. D2).

All of the data fit a three-parameter kinetic model that accounts for rates of reporter
loss and net proliferation with or without loss (Fig.4.5 A,C, D, 4.6). All fits indicate slower
net proliferation with loss; Chr-5 is lost ~4-fold faster from cells treated with MPS1i or by
confinement, relative to controls. We also fit reporter loss with power laws versus N. For
2D Ctrl cultures (where E = 0 for an overlying fluid phase), Chr-5 reporter loss Δ ~ Na with
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Figure 4.7: (Previous page) MPS1i leads to viable reporter-neg colonies and more micronuclei.
(A) MPS1 inhibitor reversine-treated cells have more micronuclei, and have a broader distribution
of cells with more than 1 micronuclei, compared with non-treated vehicle control. (n >200 cells per
condition; unpaired two-tailed t-test with Welch’s correction. ****p < 0.0001. Scale bar = 10 µm.
(B) Images of cells with more micronuclei after MPS1 inhibition. (C) Cell numbers in reporternegative colony forming units (CFUs) of iPSCs (with Chr-5 reporter) or A549s (with Chr-5, Chr9, or Chr-19 reporters) when treated with a continuous low-dose reversine or control for 3-5 days.
C. with Brandon Hayes and Junhong Du

a ~ 0.03 to 0.1 (i.e. weak scaling), whereas for rigid confinement (E >> 0) and for MPS1i
perturbations, Δ ~ Nb with b/a ~ 2.5. Power law analyses and kinetic model fits consistently
show Chr-5 loss is stress-driven by several-fold but also varies much more (~2 to 10-fold)
for other Chr’s (Fig.4.6 C). After induced loss, growth or viability in 2D also shows Chrand cell-type specific differences.

Micronuclei are also evident especially in perturbed cells, and are well-known to
harbor mis-segregated Chr’s that accumulate massive DNA damage, especially when
lamin-B levels are low (Liu et al., 2018; Hatch et al., 2013; Fig 4.7 A). Micronuclei in
perturbed cells show even more DNA damage (Fig D3). Confinement favors Chr missegregation during abnormal mitosis (Fig.4.4 A), with A549s showing many micronuclei
post-confinement. However, micronuclei are comparatively rare in iPSCs, which could
relate to near-zero tolerance of iPSCs and colonies to Chr loss in 2D-culture without MPS1i
(Fig.4.7 B, C). Indeed, MPS1i-driven Chr loss in iPSCs almost vanishes after drug
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withdrawal (Fig.4.5 D), even when using low doses and times that maintain viability of
these normal cells.

4.4 Mitosis under confinement doesn’t superimpose with MPS1
inhibition in leading to viable chromosome-loss descendants

Standard, well-established perturbations that cause losses and gains of Chr’s in
cultured cells include chemical inhibitors of microtubule (MT)-related pathways, such as
drugs targeting the MPS1 kinase that coordinates attachment of MTs to chromosomes in
the mitotic spindle (Dumont and Mitchison, 2009; Lancaster et al., 2013). Physical
confinement of mitotic cells leads to increase in cell and nuclear area, and, therefore, makes
it more difficult for microtubule to attach to kinetochore due to the relatively shorter length
of MTs emitted from centromere to kinetochore (Dumont and Mitchison, 2009; Lancaster
et al., 2013; Fig 4.8 D, E, D2).
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Figure 4.8: (Previous page) Confinement and MPS1i lead to chromosome mis-segregation
both through the Microtubule-dependent pathway and show no additive effect. (A)
Abnormal Mitosis% in dividing cells with MPS1i reversine, confinement, or combination. (B)
Confinement and MPS1 inhibitory drug reversine combined perturbation and flow cytometry
measures of Chr-5 reporter-negative A549 cells. Sub-saturating dose of MPS1i (reversine),
confinement, or combination for 4 days. (C) Another MPS inhibitory drug AZ3146 with the
optimal dose (one that gives similar RFP-neg% as confinement) was applied, instead of reversine,
to give flow cytometry measures of AZ3146 only, confinement only, or combination for 4
days. (D) Inverse of volume (proportional to density) of mitotic chromatin is plotted against its
projected area, with different heights of spacers applied. Enhanced confinement effect gives
increased area and denser compactness. n ≥ 30 cells per condition. (E) MPS1 inhibition (with
reversine) doesn’t enhance mitotic nuclear area of A549 cells, in contrast to confinement. n ≥ 45
cells. (F) Pathway and colony formation schematic for MPS1i, nocodazole, and rigid confinement
that all cause chromosome loss. Confinement increases spindle length LMT and Wchromatin.
Statistics: (A)-(C): n=3 replicates; two-way ANOVA for multiple comparisons. *p < 0.05; ns, not
significant. (D), (E): Mann-Whitney U-rank test: *p < 0.05; ns, not significant.

Two different MPS1 inhibitors at sub-saturating dose generating similar reporter-neg% as
confinement, respectively, do not show superimposed effect when applied simultaneously
with confinement, and no more increase in abnormal mitosis was observed in the
perturbation that combined MPS1i reversine and confinement compared with each one
applied individually (Fig. 4.8 A, B, &C). This further conveys that confinement and MPS1
inhibition both cause abnormal mitosis with perturbing MT attachment onto kinetochore.
MPS1i, however, doesn’t increase mitotic area, indicating it deregulates MT attachment to
kinetochore not through physically elongating the distance between centrosome and
kinetochore, but perturbing such attachment through biochemically interfered SAC
pathways. Moreover, nocodazole, as a microtubule disrupter, when treated at subsaturating dose, doesn’t show additive effect when combined with MPS1i as well, once
80
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again confirming that MPS1i leads to mis-segregation through MT-dependent pathway
(Fig. D2). Overall, MPS1i, confinement, and nocodazole all lead to chromosome missegregation through MT-mis-attachment, but as a result of chemically triggered misattachment, physically triggered, and not enough microtubules (Fig. 4.8 F).

4.5 Chromosome loss is favored by TOP2A-driven compaction
but opposed by Myosin-II

To assess possible pathways of confinement-induced changes in viable cells that
lost a chromosome, single-cell RNA-seq was applied after confinement of cells. RFP-neg
cells show down-regulation of Chr-5 transcripts, consistent with gene-dosage effects
(Fig.4.9A). These confined cells that clearly possess a genetic change are compared to
spontaneously generated RFP-neg cells and show increased expression of multiple MTs
and spindle factors (Fig.4.9A). These include the anti-apoptotic factor survivin (BIRC5)
(Li et al., 2019; Castedo et al., 2004), which suggests that mitotic cells under rigid
confinement must possess robust MT-spindle connections in order for even a fraction of
stressed cells to survive. Topoisomerase-IIα (coded by TOP2A gene) was the most
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upregulated and acts to compactify mitotic chromosomes in G2/M phase (Samejima et al.,
2012; Farr et al., 2014). Vertical confinement spreads the chromatin (Fig.4.8 D,E,D2) as
well as the cell and its mitotic spindle (Dumont and Mitchison, 2009), thus working against
chromatin compaction and potentially requiring more TOP2A for at least some cells to
maintain viability with a heritable loss. Indeed, RFP-neg cells and colonies have lost Chr5 but gain the most anti-TOP2A signal when such cells are generated by confinement
(Fig.4.9 B).

To assay TOP2A function in confined mitosis, a low, non-toxic dose of the TOP2Aspecific inhibitor etoposide (Etop) was added to confined A549s after sorting and
synchronizing cells, with unbound drug washed out after the 8h confinement. RFP-neg
cells in 2D + Etop conditions are rare and show extremely low TOP2A (Fig.4.9 C, D).
Confinement + Etop maintains the same high TOP2A and shows significantly more RFPneg cells than 2D + Etop, albeit far below the normal level imposed by confinement without
drug (Fig.4.9 C).

Distortion of mitotic chromatin within a compressed cell is opposed not by the
nuclear lamina but by the acto-myosin cortex that contributes to stiffness (Stewart et al.,
2011; Sedzinski et al., 2011). To test the role of myosin-II in protecting genetic integrity,
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Figure 4.9: Single-cell RNA sequencing shows compression-induced Chr loss associates with
chromatin-compacting Topoisomerase-IIa. (A) (i) Chr-5 loss inferred from single-cell RNAseq of ChReporter-neg, Noc-synchronized A549s after either confinement for 8h (143 cells) or
2D culture for 8h (87 cells), plus 48h recovery. ChReporter-pos cells from 2D culture were used
as a reference (163 cells). (ii) Differentially expressed genes in Chr-5 ChReporter-neg A549s
generated either from confinement or spontaneously in 2D culture. (Continued next page)
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Figure 4.9: (Previous page) TOP2A is the most upregulated gene in confined cells, with other
upregulated genes being microtubule and other mitotic genes. (B) Reporter-neg cells after
confinement shows significantly more Topoisomerase IIa intensity based on immunofluorescence.
Two-tailed t-test with Welch’s correction. (C) Top2A inhibitor Etoposide leads to decrease in
reporter-neg% regardless of confinement, but confinement still increases reporter-neg% when
Etoposide exists. Two-way ANOVA for multiple comparisons. (D) Etoposide, as an inhibitor,
decreases TopoIIa signal by more than 2 folds. Two-way ANOVA for multiple comparisons. (B)(D): n=3 replicates. *p < 0.05; **p < 0.005, ***p < 0.0005, ****p < 0.0001, ns, not significant.
A: sequencing: Mai Wang

knockdown of the major non-muscle myosin-II isoform, myosin-IIA (coded by MYH9
gene), was done in rapidly dividing iPSCs with the Chr-5 reporter system (Fig.4.10 C).
Similar knockdown with shRNA in embryonic mouse skin by Fuchs & coworkers led to
carcinoma (Schramek et al., 2014), suggesting myosin-IIA has a tumor suppressor role as
described also by others (Picariello et al., 2019). Evidence of genetic changes (as required
for cancer) has remained unclear as has relevance to human cells, but skin is a relatively
stiff and 3D microenvironment (Martincorena et al., 2015).

Compression of myosin-IIA knockdown cells not only increases visibly abnormal
mitosis (Fig. D5) but also increases the percentage of RFP-neg cells versus controls
(Fig.4.10 D). Importantly, the same increase is seen with myosin-II inhibitor blebbistatin
added only during the 8h confinement, with such a brief drug treatment affecting the levels
of very few proteins compared to knockdown (Raab et al., 2012). Neither blebbistatin nor
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knockdown enhance the basal instability for percentage of RFP-neg cells in 2D cultures.
Although myosin-IIA depletion can increase proliferation of some cancer cell types in 2D
(Picariello et al., 2019) and 3D (Han et al., 2020), it has the opposite effect on normal stem
cells in mechanically stressed skin (Aragona et al., 2020), and we find knockdown slows
A549 proliferation only slightly and that mitosis in confinement is delayed but not stopped.
To provide an additional test of the effects of abnormal mitosis versus proliferation rate,
A549 cells were plated on a dense collagen-coated substrate that can severely limit
spreading of some cell types (Engler et al., 2004) and indeed increases abnormal mitosis
while slowing proliferation (Fig. D5). Myosin-IIA knockdown and shCtrl A549s show
equal increases in the percentage of RFP-neg cells relative to standard 2D cultures, which
again indicates that microenvironment-regulated abnormal mitosis better predicts
chromosome loss than does the simple number of divisions N (Fig. 4.10 A, D5).

To better model division in dense 3D collagenous tissues (e.g. dermis; Schramek,
et al., 2014;), A549s on the collagen-coated substrates were compressed. Only knockdown
cells showed an increase in RFP-neg cell %, which suggests that myosin-IIA mechanoprotects a cell’s genetic integrity in microenvironments that are highly constraining
laterally as well as vertically (Fig.4.10 A, B, D6). Hence, the general finding that shMYH9
and transient blebbistatin do add to confinement-induced instability differs again from
transient MPS1i but aligns well with blebbistatin not disrupting MT-driven mitosis in
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standard 2D culture (Straight et al., 2003), unlike MPS1i and Noc (Fig.4.8). Earlier
observations that myosin-IIA has a tumor suppressor role in that its knockdown can lead
to cancer in a relatively stiff tissue such as skin (Schramek, et al., 2014) might thus be
explained by actomyosin protecting against chromosome loss in constraining 3D
microenvironments.

4.6 Discussion

The hypothesis that mitosis within rigidly-constraining 3D microenvironments
causes heritable mechanogenetic changes is supported by the mono-allelic chromosome
reporter approach that directly reveals stress-driven, stiffness-associated generation of rare
GFP/RFP-negative cells (~1%) that are to varying extent viable in vitro with conditions
simulating in vivo. Traditional and Next-generation Genetic methods all support the
approach. Although such conclusions seem to be lacking from reports of single cell genetic
analyses to date, various genetic changes across normal tissues and tumors do appear
maximal at high tissue stiffness and high tissue proliferation, with the efficacy of cancer
immunotherapy also showing the same trend and highlighting a broader significance.
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Figure 4.10: Myosin IIa protects against mitotic rounding and leads to more reporterneg% once inhibited or knocked down. (A) RFP-neg cells occur more frequently on
collagen-coated gels versus plastic, independent of Myosin-IIa knockdown, unless confined
under a rigid coverslip. (B) Confinement applied on A549 shCtrl cells without doesn’t lead
to more RFP-neg%, while on A549 shMYH9 cells does more, albeit the fold change is still
lower than on plastic. Data is normalized with respect to each unconfined counterpart. (C)
Western blot shows successful 80% knockdown of Myosin Iia. (D) Flow cytometry analysis
of iPSC Chr-5 reporter-negative cells with myosin-IIA knockdown or inhibition (with
blebbistatin) under rigid confinement or not. Myosin-IIa knockdown and Inhibition both
show increase in reporter-neg% with confinement compared to shCtrl. n = 4 replicates; 3way ANOVA with Tukey’s correction for multiple comparisons. *p < 0.05, **p < 0.005,
***p < 0.0005, ns, not significant.
A. Some data recruited from Brandon Hayes’s experiment. C. shMYH9 Engineering:
Brandon Hayes; D. confined: Brandon Hayes
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A solid tissue such as normal lung (with high stiffness E) and its associated tumors
shows low proliferation but more genetic change than a highly proliferative liquid tissue
such as blood (E=0) and its associated hematopoietic cancers. Unsurprising is the fact that
mechanical stress and 3D-rigidity can kill cells, and so the question becomes whether some
stressed cells survive with changes as visibly tracked by the reporter approach.
Assumptions of error-free division are clearly flawed and become unnecessary compared
to standard approaches with “clonal expansion” and genetic analyses. Visible and sustained
functional genetic changes can quickly result from 3D compression (Fig.4.4) that can
distort the mitotic spindle and increase chromosome mis-segregation as is associated, for
example, with altered tissue architecture (Dumont and Mitchison, 2009; Lancaster et al.,
2013; Matthews et al., 2020; Knouse et al., 2018). The approach could further address
whether viable changes to a cell’s DNA also result from 2D matrix stiffness modulation of
the lifetime of chromosome bridges (Umbreit et al., 2020).

Cytokinesis in rigid yeast normally requires myosin-II, with its deletion somehow
causing viable chromosome losses and gains (Rancati et al., 2008), which suggested a
genome protective role. Indeed, under the stresses of rigidity confined mitosis and distinct
from standard 2D-culture, genetic integrity is regulated (positively) by MYH9 and
(negatively) by TOP2A. MYH9 might directly regulate the “guardian of the genome” p53
and explain the presumed genetic changes that lead to cancer in MYH9 knockdown mouse
skin but results for mouse tongue seem to differ (Schramek et al., 2014; Conti et al., 2015).
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In standard 2D-cultures of a cardiomyocyte tumor line, nonmuscle myosin-II
depletion increases abnormal mitosis and cell death as well as MT acetylation-stabilization
(Ma et al., 2010), which has been linked to a phosphatase that inhibits both myosin-II
contractility and a MT-targeting de-acetylase (Joo and Yamada, 2014) but also linked to
aneuploidization in breast cancer (Sudo, 2018). Although increased Chr loss with MYH9
depletion in 3D-confinement is distinct from MT based processes and from processes in
2D (Fig.4.8 vs Fig.4.10), the reporter approach allows molecular mechanisms to be further
addressed by specifically interrogating cells with clear, heritable loss of Chr’s. Indeed,
unbiased analyses of cells with heritable Chromosome loss after confined mitosis revealed
TOP2A induction (Fig.4.9), and this could reflect mechanosensitive pathways based on
ChIP-Seq showing serum response factor (SRF) binding to TOP2A as well as MYH9 genes.
The finding that TOP2A remains high for days or more after confinement (>1-2 cell
cycles) is further consistent with a 'mechanical memory' such as that associated with
proliferation-regulating transcriptional co-factor YAP1 (YES-associated protein-1) in cells
grown on rigid but not soft substrates (Yang et al., 2014). Stretching of mouse skin also
induces nuclear translocation of YAP1 and key SRF factors downstream of MYH9, with
both pathways essential to DNA replication in epidermal stem cells (Aragona et al., 2020).
Physically, lateral stretching tends to vertically compress cells via the Poisson effect, with
direct roles on mitosis and specific factors such as TOP2A requiring further study particularly while focused on viable, rare cells with a specific heritable genetic change.
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DNA sequence certainly confers long-term biological memory, and so mechanogenetic
changes to a cell’s DNA likewise confer mechanical memory.

4.7 Materials and methods
Cell lines and tissue culture
A549 cells were cultured in Ham’s F-12 media (Gibco 11765047) supplemented with 10%
(v/v) fetal bovine serum (FBS; MilliporeSigma, Catalog no. F2442) and 100 U ml -1
penicillin-streptomycin (Gibco, Catalog no. 15140122). All cells were passaged every 2-3
days using 0.05% Trypsin/EDTA (Gibco, Catalog no. 25300054). All A549 cells were
incubated at 37oC and maintained at 5% CO2.The original A549 RFP-LMNB1 cell line
was engineered by Sigma-Aldrich. The A549 cell line was obtained from the American
Type Culture Collection (ATCC).

The following induced pluripotent stem cell (iPSC) lines were also used, all of which were
acquired from the Coriell Institute for Biomedical Research and generated/validated by the
Allen Institute for Cell Science: iPSC GFP-LMNB1 (AICS-0013 cl.210), iPSC RFPLMNB1 GFP-SEC61B (AICS-0059 cl.36), and iPSC FBL-GFP NPM1-RFP (AICS-0084
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cl.18). iPSCs were cultured in mTseR Plus medium (STEMCELL Technologies, Catalog
no. 05825), with mTser Plus 5X supplement and 100 U ml-1 penicillin-streptomycin. For
passaging and maintenance of iPSCs, cells were lifted with accutase (Sigma, Catalog no.
A6964) at 37oC and re-plated into 10-cm plates (Corning) coated with Matrigel (Corning,
Catalog no. 356231) following the Allen Institute of Cell Science’s protocol. 10 mM
ROCK inhibitor (Y-27632; STEMCELL Technologies, Catalog no. 72302) was added to
replated cultures to help with adherence and to prevent differentiation. Passaging was done
once iPSC cultures reached 70% confluency to prevent spontaneous differentiation. All
iPSC lines were also cultured at 37oC and maintained at 5% CO2.

Single cell RNA-sequencing
RNA libraries were constructed using the Chromium Single Cell Gene Expression kit
(v3.1, single index, Catalog no. PN-1000128; PN-1000127; PN-1000213) from 10X
Genomics per the manufacturer’s instructions. The libraries were submitted to the
University of Pennsylvania’s Next Generation Sequencing Core for sequencing using
NovaSeq 6000 (100 cycles) from Illumina. Raw base call (BCL) files were analyzed using
CellRanger (version 5.0.1) to generate FASTQ files and the “count” command was used to
generate raw count matrices aligned to GRCh38 provided by 10x genomics. For teratoma
samples, FASTQ files were aligned to both GRCh38 and GRCm38. The cells are labeled
to be human/mouse cells if more than 90% of the UMIs are aligned to GRCh38/GRCm38.
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The data generated was imported as a Seurat object (4.0.0) for future downstream analysis
(2). Cells were filtered to make sure that they expressed 500 and 6,000 genes inclusive and
had less than 10 percent mitochondrial content. Data was normalized using the
“LogNormalize'' method or sctransform package (0.3.2) (3). Differential expression
analysis was performed using the “FindAllMarkers'' command and the output was used for
the volcano plot. The very first 30 dimensions were used to generate UMAP. Cell cycle
analysis was performed using “CellCycleScoring'' command.

Cell type annotations
Raw expression matrices were used as the input for the singleR (1.4.1) package (Aran et
al., 2019). The cell types were annotated based on Human Primary Cell Atlas (Mabbott et
al., 2013).

Monoallelic chromosome tagging
For all attempted monoallelic chromosome reporters as described in Fig. 1E, all donor
constructs were a gift from Allen Institute of Cell Science: AICSDP-8:TOMM20-mEGFP
(Addgene plasmid #87423; http://n2t.net/addgene:87423;

RRID:Addgene_87423),

AICSDP-13:FBL-mEGFP (Addgene plasmid #87427; http://n2t.net/addgene:87427;
RRID:Addgene_87427), AICSDP-35:AAVS1-mEGFP (Addgene plasmid #91565;
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http://n2t.net/addgene:91565; RRID:Addgene_91565), AICSDP-42:AAVS1-mTagRFPTCAAX

(Addgene

RRID:Addgene_107580),

plasmid

#107580;

AICSDP-1:PXN-EGFP

http://n2t.net/addgene:87420;

http://n2t.net/addgene:107580;
(Addgene

RRID:Addgene_87420),

plasmid

#87420;

AICSDP-10:LMNB1-mEGFP

(Addgene plasmid #87422; http://n2t.net/addgene:87422;

RRID:Addgene_87422),

AICSDP-52:

plasmid

HIST1H2BJ-mEGFP

(Addgene

#109121;

http://n2t.net/addgene:109121 ; RRID:Addgene_109121), AICSDP-7:SEC61B-mEGFP
(Addgene plasmid # 87426; http://n2t.net/addgene:87426; RRID:Addgene_87426).

All knock-in reporter lines were generated following the protocol established in (1)
using CRISPR/Cas9 technology. Donor plasmids were designed such that unique designs
for each target locus contain 5’ and 3’ homology arms (1 kb each) for the desired insertion
site, based on the GRCh38 reference human genome. For editing, we use the ribonucleic
protein (RNP) method with recombinant wild type S. pyogenes Cas9 protein precomplexed with a synthetic CRISPR RNA (crRNA) and a trans-activating crRNA
(tracrRNA) duplex. Recombinant wild-type Cas9 protein was purchased from the
University of California–Berkeley QB3 Macrolab, while crRNA and tracrRNA
oligonucleotides were designed by and purchased from Horizon Discovery. For
transfection of donor templates into target cells, we used the electroporation using a Gene
Pulser Xcell Electroporation System (Bio-Rad). 700,000 targets cells were lifted using
0.05% Trypsin/EDTA, resuspended in 200 ul of fresh media without penicillin93
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streptomycin, and loaded into a 0.4-cm cuvette. 4 µL of both 10 µM crRNA:tracrRNA
duplex and 10 µM recombinant Cas9 protein were added to the cell solution, as well as 8
µg of donor plasmid. Electroporation conditions were as follows: (1) A549 and H23: 200V
with 45 ms pulse length using a square-wave protocol; (2) U2OS: 160V with 30 ms pulse
length using a square-wave protocol. After electroporation, cells were allowed to expand
for ~1 week and then enriched via fluorescence-activated cell sorting (FACS), as described
below. 3-5 FACS enrichment cycles were performed to achieve a pure reporter-positive
population.

Lentiviral packaging and delivery
MYH9 silencing was performed by lentiviral-driven expression of short-hairpin RNAs
purchased from Sigma-Aldrich, using the pLKO backbone construct. The following
shRNA

were

used:

TRCN0000285480,

TRCN0000029468,

TRCN0000029466,

TRCN0000276055, and TRCN0000276070. For non-targeting shRNA control, the pLKOsh-HSC plasmid was a gift from Do-Hyung Kim (Addgene plasmid # 46896 ;
http://n2t.net/addgene:46896 ; RRID:Addgene_46896). Lentivirus was produced in
HEK293T cells using MirusBio TransIT-Lenti Transfection Reagent (Catalog no. MIR
6604) following the manufacturer’s protocol. Lentiviral production was allowed to occur
for 48h, after which the supernatant was collected. Lentivirus was concentrated and
purified from traces of fetal bovine serum using the PEG-it Virus Precipitation Solution
(System Biosciences, Catalog no. LV810A-1) following the manufacturer’s protocol.
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Infected cells were selected by incubation using 1 μg ml-1 puromycin (Corning, Catalog
no. 61385RA).

Treatments
For all cancer cell treatments, either 300,000 cells were plated per well in a 6-well plate
(Corning) or 60,000 cells per well in a 24-well plate (Corning). For iPSC treatments,
60,000 cells were plated per 6-well plate. The following chemical treatments were used:
MPS1 inhibitor reversine (Cayman Chemical, Catalog no. 10004412), MPS1 inhibitor
AZ3146 (Cayman Chemical, Catalog no. 19991), TOP2A inhibitor etoposide (Cayman
Chemical, Catalog no. 12092), nocodazole (MilliporeSigma, Catalog no. M1404),
blebbistatin (MilliporeSigma, Catalog no. 203389), GSK-3 inhibitor CHIR-99021
(MilliporeSigma, Catalog no. SML1046), and dimethyl sulfoxide (DMSO; Millipore
Sigma, Catalog no. D2438). The reversine concentrations and treatment times used, unless
otherwise stated, are: for A549, 0.1 µM for 72h; for U2OS and H23, 1.5 µM for 24h
followed by washout and 48h recovery; for iPSCs, 0.25 µM for 24h followed by washout
and 24-48h recovery. All AZ3146 treatments were done at 1.5 µM for 24h followed by
washout and 48h recovery. Non-confinement etoposide studies were done at 1 µM for 24h
followed by washout and 48h recovery. For APC complex antagonism, 5 µM CHIR-99021
was used. For myosin-IIA inhibition studies, blebbistatin was used at 20 µM for 24h
followed by washout and 48h recovery or used at the same concentration for the entire of
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a confinement session. For all cell-cycle synchronization, nocodazole was added to cells at
a final concentration of 50 ng ml-1 for 12-18h. For reversine treatments paired with either
nocodazole or confinement, ony 50 nM concentration was used.

Flow cytometry and FACS.
All flow cytometry was performed on a BD LSRII (Benton Dickinson) and analyzed with
FCS Express 7 software (De Novo Software). All studied cell lines were detached by brief
trypsinization (for all cancer lines in 2D culture) or with accutase (for iPSCs), washed, and
resuspended in FACS buffer (PBS + 5% FBS) with 1.0 µg ml -1 DAPI (MilliporeSigma,
Catalog no. 09542). For fluorescence-activated cells sorting, or FACS, cells were prepared
in the same way as described above except that freshly prepared sterile FACS buffer was
used and no DAPI was included. FACS was performed on either a BD FACS Aria II or a
BD FACS Jazz. Prior to any assay that assessed reporter-negative subpopulation
generation, cells were FACS-enriched for only reporter-positive cells.

For gating, forward scatter parameters FSC-A vs. FSC-H and side scatter parameters SSCA vs. SSC-H were used to remove aggregates from analysis. Live cells were gated on using
forward scatter and side scatter (FSC-A vs. SSC-A). DAPI was further used to discriminate
between live cells and debris/dead cells.
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Antibodies
Antibodies used in this study are as follows: anti-alpha/beta tubulin (Cell Signaling
Technology, Catalog no. 2148S), anti-Myosin-IIA (Cell Signaling Technology, Catalog
no. 3403S), anti-TopoIIalpha (Santa Cruz Biotechnology, Catalog no. sc-365916), antibeta-actin (santa Cruz, Catalog no. sc-47778), and AlexaFluor 647 donkey anti-mouse IgG
(H+L) secondary (Invitrogen, Catalog no. A31571), and AlexaFluor 647 donkey antirabbit IgG (H+L) secondary (Invitrogen, Catalog no. A31573). For Western blotting, ECL
anti-mouse IgG horseradish peroxidase (HRP) linked whole antibody (Cytiva, Catalog no.
NA931V) and ECL-anti-rabbit IgG HRP linked whole antibody (Cytiva, Catalog no.
NA934V) were used.

Immunoblotting
Western blotting was performed using standard methods. In brief, cells were briefly
trypsinized, washed 3x with cold PBS, and then lysed in RIPA buffer (150 mM NaCl, 1%
NP-40 alternative, 0.5% sodium deoxycholate, 0.1% SDS, 40 mM Tris pH 8.0). RIPA
buffer also contained 1X protease inhibitor cocktail (Millipore Sigma, Catalog no. P8340).
After lysis, centrifugation was done to discard lipids and other contaminants. Samples were
then boiled in 1X NuPage LDS sample buffer (Invitrogen, Catalog no. NP0007) with 2.5%
v/v β-mercaptoethanol. Approximately 1.0 ✕ 106 cells were used for each analysis.
97

4. Mitosis under confinement leads to viable and heritable descendants, results from mechanically triggered MT mis-attachment, and
is protected by Myosin II

Proteins were separated by electrophoresis on NuPAGE 4-12% Bis-Tris gels run with 1X
MOPS buffer (Invitrogen, Catalog no. NP0323), or 3-8% Bis-Tris gels run with 1X Tris
Acetate buffer (Invitrogen, Catalog No. LA0041; Myosin-IIA samples only) and
transferred to an iBlot nitrocellulose membrane (Invitrogen, Catalog no. IB301002). The
membranes were cut into strips corresponding to one lane loaded with lysate and one lane
loaded with a molecular weight marker and then blocked with 5% nonfat milk in Tris
buffered saline (TBS) plus Tween-20 (TBST) for 1h. The membranes were washed with
TBST and incubated with 1:500 secondary antibody conjugated with horseradish
peroxidase in 5% milk in TBST for 1 h at room temperature with agitation. The membranes
were washed again with TBST, then TBS, and developed with a 3,3’,5,5’tetramethylbenzidine (TMB) substrate (Genscript L0022V or Sigma T0565). Developed
membranes were scanned and analyzed with ImageJ (National Institutes of Health).

Immunofluorescence and imaging
Cells were fixed in 4% formaldehyde (Thermo Fisher Scientific, Catalog no. 28908) for 15
min, followed by permeabilization by 0.5% Triton-X (MilliporeSigma, Catalog no.
112298) for 15 min, and blocked with 5% bovine serum albumin (BSA; MilliporeSigma,
Catalog no. A7906) for 30 min and overnight incubation in primary antibodies (1:500
dilution). The cells were then incubated in secondary antibodies (1:500 dilution) for 1.5h,
and their nuclei were stained with 8μM Hoechst 33342 (Thermo Fisher, Catalog no. 62249)
for 15 min. When mounting is involved, Prolong Gold antifade reagent was used
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(Invitrogen, Catalog no. P36930). Micronucleated cells were classified manually by
distinct staining by Hoescht 33342 of structures outside of the main nucleus.
Epifluorescence imaging was performed using an Olympus IX71 with a digital camera
(Photometrics) and a 40x/0.6 NA objective. For certain samples, confocal imaging was
performed on a Leica TCS SP8 system with a 63x/1.4 NA oil-immersion. Live imaging
was performed on an EVOS FL Auto Imaging System with 10× or 20x/0.6 NA object in
normal culture conditions (37°C and 5% CO2; complete culture medium as specified
above).

MPS1 inhibition kinetics and CFU studies
For MPS1i studies, A549 cells were originally plated at a density of 30,000 cells per 24well after FACS enrichment for reporter-positive cells and then treated with 0.1 µM
reversine continuously for 9 days. Cells were then allowed to recover for 3-4 weeks. Cells
were passaged whenever they approached ~80% confluency (every ~3 days) and a sample
of the passaged population was analyzed via flow cytometry. Whenever cells were
passaged within the first 9 days, they were replated in fresh media with reversine.

For all colony-forming units (CFU) studies, A549 cells were continuously treated
with 0.1 µM for 3-5 days to allow for generation of identifiable reporter-negative CFUs.
Cells were plated at a low density (~20,000 cells per 6-well) to avoid passaging in the
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allotted time frame. For iPSCs, cells were treated with reversine following the previously
described treatment. CFUs were identified via microscopy using an Olympus IX inverted
microscope with a 40x/0.6 NA or 20x/0.4 NA objective and equipped with a sCMOS
camera (Photometrics Prime). Images were quantified using ImageJ software.

In vitro mechanical confinement assays
Prior to all mechanical confinement assays, A549 cells were FACS-enriched for reporterpositive cells only, as described in Flow cytometry and FACS. iPSCs did not have to be
FACS-enriched, as these cultures usually maintained below a 0.1% reporter-negative
population even after continuous culture for ~1 year, suggesting genomic stability. The
night prior to assay, 30-mm glass coverslips were coated with RainX (glass water repellent
PDMS; RainX Company, Catalog no. 1597562) and then left in PBS under ultraviolet light
for sterilization overnight. For assay, A549 cells were plated at 300,000 cells per 6-well.
Roughly 24h later after which cells had settled and adhered, they were treated with
nocodazole at a concentration of 50 ng ml-1 to allow for synchronization. At the same time,
6.58-µm polystyrene beads (SpheroTech, Catalog no. SVP-60-5) were added at the same
density as the cells during this time. These polystyrene beads served as spacers to control
the height of mechanical confinement and would also adhere to the cell culture plastic after
the synchronization time period. After 12-18 hours of nocodazole synchronization, cells
were gently washed 5X with PBS and then replenished with 1.5 mL of fresh media. Then,
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sterile, RainX (PDMS)-coated 30-mm glass coverslips were gently placed on top of the
cells. A sterilized, stainless steel weight was then placed on top of the coverslip to complete
confinement. The complete confinement setup (stainless steel weight with PDMS-coated
glass coverslip) was removed after 8-10h, cells were gently washed with PBS, and fresh
media was added to the recently confined cultures. Cells were allowed to grow for 2 days
before brief trypsinization and flow cytometry quantification of the generation of reporternegative cells. A subset of these cells were also plated back for repeated confinement cycles
as necessary. Etoposide studies (Fig.2C) follows the synchronization protocol, and the drug
was added only during confinement, and washed out afterwards.

All iPSC and non-nocodazole synchronized A549 confinement studies followed the
same exact procedure as the original nocodazole-synchronized A549 experiment with the
exception of nocodazole synchronization. iPSCs were plated at 600,000 cells per 6-well,
while A549s were still plated at the original density. Roughly 2h before confinement, spent
media was discarded and replaced with fresh media containing the 6.58-µm polystyrene
spacer beads to allow beads to settle. Then, cells underwent the same exact mechanical
confinement assay. iPSCs only underwent a single cycle (one ~8h confinement).
Unsynchronized A549 cells underwent four sessions of 8h confinement for short-term
studies or 12 sessions for long-term kinetics studies. These A549 cells were passaged as
needed to avoid over-confluency.
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The MPS1 inhibitors reversine and AZ3146, when applied simultaneously with
confinement (Fig.2A-B), followed the schematic timeline outlined in (Fig. S3D). Drugs
were gently washed out with PBS after confinement. Their corresponding dose testing
experiments (Fig.S9D) were conducted with the same timeline, except that confinement
was replaced with different doses of MPS1 inhibitory drugs.

Live-imaging of in vitro mechanical confinement
For live-imaging of mechanical confinement, A549 cells with monoallelic GFP-H2B cells
or iPSCs with Hoescht 33342 staining were used and prepared accordingly as described
previously. Images were taken while cells underwent confinement every 20 min using
Olympus IX71 with a digital camera and a 20x/0.4 NA objective. For all confinement
assays, an unconfined 2D control was maintained. The 2D control culture was plated at
roughly a quarter of the density used for the confined cultures so that both samples could
be passaged simultaneously later on. For abnormal mitosis analysis of MPS1i combined
with confinement, samples were first synchronized. Then, MPS1i was added to the samples
for the same duration as a confinement experiment (with or without actual confinement
occurring). Measurements were taken at specified time points, but the locations were not
strictly maintained.
To quantify cell death resulting from confinement, we used A549 cells with the
Chr-5 RFP-LMNB1 reporter and a GFP-H2B tag for nuclear localization and viability
assessment. Cells were synchronized with nocodazole as previously described, and after
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nocodazole washout, fresh media with 1 µM DAPI was added. Cells were then incubated
at 37oC for ~5 min for DAPI to diffuse and penetrate. Well plates were marked with dots
on bottom prior to assay, and images were taken to define the status of cells prior to
confinement. Afterwards, confinement continued normally for ~8h as described
previously, with images taken at distinct timepoints at the same marked locations. Spent
media was discarded and replaced with fresh media with 1 µM DAPI again 27h for a ~10min incubation after the assay initially began (and for all subsequent imaging timepoints)
for live/dead discrimination. Images were taken again at marked locations. Media with
DAPI was always discarded after imaging and replaced with fresh culture media.

Quantification of abnormal mitosis during confinement using confocal microscopy
Both A549 cells and iPSCs were plated at the same densities described in In vitro
mechanical confinement assays on top of sterile 30-mm glass coverslips. For A549s,
nocodazole synchronization was done as previously described. Polystyrene spacer beads
were also added to cultures as previously described. On the day of assay, 1.5 mL of
complete culture media per well was added to as many wells of an ultra-low attachment 6well plate (Corning) as needed. The 30-mm glass coverslips with the cells adhered to them
were then flipped upside down and transferred to the ultra-low attachment 6-well to create
a “sandwich” in which the cells were between plastic and glass layers. A sterile stainless
weight was then added to the top of the glass coverslip to begin confinement. After 1-2h
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had elapsed, the weight was removed, and the glass coverslip with cells was flipped back
to its original position (so cells were no longer sandwiched) and transferred to a clean 6well plate for fixation using 4% paraformaldehyde. Confocal imaging was performed on a
Leica TCS SP8 system with a 63x/1.4 NA oil-immersion.

Image acquisition for measurement of chromatin height during confinement
For unconfined measurements of chromatin, both A549 cells and iPSCs were plated at the
same densities described in In vitro mechanical confinement assays on top of sterile 35mm glass bottom petri dishes (MaTek, Catalog no. p35G-1.5-14-C). For A549s,
nocodazole synchronization was done as previously described. After nocodazole release,
cells were stained with 8 μM Hoechst 33342 for at least 15 min prior to imaging. For
measurements under confinement, both A549 cells and iPSCs were plated at the same
densities described in In vitro mechanical confinement assays on 30-mm glass coverslips.
For A549s, nocodazole synchronization was again done as previously described. After
nocodazole release, cells were replenished with fresh culture media with 8 μM Hoechst
33342 for DNA staining. The glass coverslip with cells was then flipped upside down and
placed on top of a 40-mm length rectangular glass coverslip with 30 μl droplet of 6.58-μm
polystyrene spacer beads in complete media (prepared prior to DNA staining) to complete
the confinement sandwich. One or more stainless steel metal weights were then added on
top of the top coverslip to initiate confinement. For tumor/teratoma chromatin height
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measurements,

freshly

harvested

samples

were

fixed

overnight

using

4%

paraformaldehyde at 4°C, permeabilized using 0.5% (v/v) Triton-X for 1h at room
temperature, and finally stained with Hoescht 33342 overnight at 4°C. Small
tumor/teratoma sections were sliced, submerged in 20-40 μl of PBS on a rectangular
coverslip (either 35x50 or 45x50 mm2). All samples were imaged using a Leica TCS SP8
system with a 63x/1.4 NA oil-immersion. All images were taken every 0.5 μm along the
focus (Z stack) to cover the entire nuclei, whether it be interphase or mitotic. All image
stacks were 3D-reconstructed using ImageJ. The first frame was used as the top view, and
the tenth frame was used as the side view in a 36-frame 3D construction profile. For
tumor/teratoma sections, the thinnest portion of the nucleus is treated as the height, due to
the 3D nature of the sample preventing determination of the nucleus orientation.

Cell growth curves
At t = 0h, RFP-positive and RFP-negative clones (P3 and N3, respectively) were each
seeded in a 24-well plate at extremely low density (2.6 ✕ 102 cells/cm2). Starting at t = 24
h, every 24h for 96h total, tile scanning was used to image one-half of each sample well.
Imaging was performed on an Olympus IX71—with a 10x/0.2 NA objective—and a digital
EMCCD camera. For every timepoint, the number of cells in each half-well was manually
counted from the images, and then multiplied by two to get the total number of cells per
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well, or the total population of each experimental condition. Fits to the exponential growth
equation y = aekx exclude t = 0h, where cell density is merely an estimate, and fits to y =
10mx + b exclude t = 0h and t = 96h.

Data reporting
Statistical methods were not used to predetermine sample size. The experiments were not
randomized. Investigators were not blinded to allocation during experiments and outcome
assessment.

Statistics and reproducibility
The statistical methods for each experiment are included in the corresponding Figure
legends. All statistical analyses were done on GraphPad Prism 9.0. All experiments were
biologically repeated and confirmed. Unless otherwise mentioned, all plots show MEAN
± SEM, and statistical comparisons are considered significant if p<0.05. n indicates the
number of samples, cells, wells, etc. quantified in each experiment. Additionally, at least
two separate investigators performed each experiment separately for reproducibility.
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Chapter 5
In vivo condition and cell division lead
to increase in genomic variation
Fig. 5.2 (A) iPSC-GFPLMNB1 part, some replicated data in Fig. 5.3 B, Fig. 5.5 B & C have
been recorded in Live cell monitoring for factors affecting genome variation, Biorxiv, 2018, by Xia,
Y., Zhu, K., Irianto, J., Andrechak, J.C., Dooling, L.J., Pfeifer, C.R., Discher, D.E. All mouse
injections involved in this chapter (displayed in Fig. 5.1) were conducted by Jason
Andrechak. Cell dissociation was conducted by Kuangzheng Zhu, Jason Andrechak, and
Brandon Hayes. Dr. Yuntao Xia took iPSC-GFPLMNB1 images for Fig. 5.2 A, conducted
sequencing in Fig. 5.5 B along with Dr. Jerome Irianto, and drew path for Fig. 5.5 C;
Brandon Hayes took iPS-RFPLMNB1 images for Fig. 5.2 A, performed iPSC-RFPLMNB1
flow cytometry for Fig. 5.2 B, calculated all bottom panel data for Fig. 5.3 and executed flow
analyses for Fig. 5.3 A and some Fig. 5.3 B, contributed to in vivo data to Fig. 5.4 D; Dr.
Charlotte Pfeifer drew Fig. 5.5 A, arranged and replotted data for Fig. 5.5 E-F. Kuangzheng
Zhu conducted Fig. 5.4 A-C, 5.5 D, took A549-RFPLMNB1 images for Fig. 5.2 A,
performed iPSC-GFPLMNB1 and A549-RFPLMNB1 flow cytometry for Fig. 5.2 B,
executed flow analyses for Fig. 5.3 C and some Fig. 5.3 B, prepared cells for Fig. 5.5 B,
performed experiments and generated raw data for Fig. 5.5 C, performed experiments and
calculated persistence length, cell shape information raw data for Fig. 5.5 E-F.
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5.1 Introduction

Adherent cells growing in vitro and suspending cells are surrounded by a
microenvironment more similar to liquid tumor and soft tissues than solid, stiff tumor.
Adherent cells, with one side anchored on a petri dish while the other side submerged in
liquid media (with similar density to water and serum), do not receive stretching and
compressing forces from cells located on another layer, and can freely form rounded shape
at prometaphase for chromosome alignment, while cells in 3D conditions or divide within
confined space cannot. Last chapter has concentrated on applying mechanical confinement
on cells growing in 2D culture to lead to chromosome mis-segregation followed by increase
in reporter-neg%, while this chapter proceeds from mimicking to realistic 3D in vivo
conditions, where different reporter cell types grow as xenografts to form tumors or
teratoma with their reporter-neg% measured as the evaluation marker of genomic variation.
The relationship between cell division in tumor and in vitro are compared, to further prove
that both stiff 3D environment and cell division contribute to genomic variation.

Additionally, different A549 reporter-positive clones used for xenografts have
phenotypical differences that bring our insights to chromosomes that can potentially be
targeted with reporter system, as well as the meaningful consequences in phenotype
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Figure 5.1: Schematic diagram of xenograft formation and harvest. Human cells xenografted at
subcutaneous sites in immunodeficient NSG mice. When the iPSC teratomas or A549 tumors grew to a
diameter of ~2 cm, they were harvested, disaggregated, and analyzed for Chr-5 reporter loss.

changes from genotype, once again confirming the widespread concept of central dogma:
DNA-RNA-Protein.

5.2 In vivo condition generates heritable Chr loss reporter cells,
and reporter-neg% scales with division more than in vitro

Immunodeficient mice were subcutaneously inoculated with human iPSCs or
A549s expressing the LMNB1 Chr-5 reporters (Fig.3.1,3.2). Teratomas derived from iPSCs
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A
Figure
5.2:
Flow
cytometry
shows
increase of reporterneg% in vivo than in
vitro,
verified
by
imaging.

(A) Images of Chr-5
reporter loss (LMNB1
protein) in 2D-cultures
(~1 wk) of cells derived
from iPSC teratomas
(both clones) or from
A549 tumors. Mouse
cells show distinctive
chromocenters
in
Hoechst stain of DNA.
All Scale bars = 10 µm.

B

(B) Representative flow
charts
and
gating
strategies of reporter
positive and negative
distribution of in vitro
reporter cells or reporter
cells dissociated from
mouse xenografts.

A: with Yuntao Xia and
Brandon Hayes
B: with Brandon Hayes
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A

B

C

Figure 5.3: Increased reporter-neg% cells in iPSCs end up dead in most xenografts, while
A549s show some growth. Quantitation of Chr-5 reporter-negative cells from various teratomas or
tumors versus in vitro cultures, including 3-5 wk cultures post-harvest for assessments of persistent
viability. n = 3 - 14 replicates; unpaired two-tailed t-test with Welch’s correction between each
confinement condition and its respective unconfined, standard 2D control. **p < 0.005, ***p <
0.0005, ****p < 0.0001, ns, not significant. (A) iPSC RFP-LMNB1; (B) iPSC GFP-LMNB1 (C)
A549 RFP-LMNB1, clones P1,P2,P3.

with Brandon Hayes

have not yet been reported to cause genetic changes despite their wide use in stimulating
differentiation (Gutierrez‐Aranda et al., 2010; Nelakanti et al., 2015, Cunningham et al.,
2012), and bulk genetics analyses of tumor xenografts have argued against de novo changes
(Woo et al., 2021). iPSC teratomas and A549 tumors (Fig.5.1) were harvested after ~2-3
months, flow-sorted for fluorescent-negative cells, and analyzed by bulk genetics methods,
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which confirmed in vivo loss of Chr-5 (Fig. C3). The result rules out rare epigenetic
changes (Shaffer et al., 2017). Cultures of disaggregated teratomas and tumors show rare
human cells lack nucleus-localized GFP/RFP-LMNB1 (Fig.5.2 A) while immunostaining
for human proteins including lamin-A (Fig. E1). The latter also serves as a differentiation
marker for teratomas. A few mouse cells adhere in culture but possess distinctive nuclei
with chromocenters (Fig.5.2 A). Importantly, flow cytometry analyses showed Chr-5
reporter-negative cells increased in all teratomas and tumors (Fig.5.2 B, Fig.5.3 top) based
on identification with various human-specific markers (e.g. GFP-SEC61B in iPSCs; Fig.
3.2, 3.3). The iPSCs showed ~30-fold more loss of GFP-LMNB1 than time-matched,
genetically stable controls; and distinctly edited iPSCs showed ~4-fold more loss of RFPLMNB1 than time-matched 2D cultures. A549 tumors of three sub-clones (P1, P2, P3) also
showed 2- to 10-fold more loss of Chr-5 versus standard 2D cultures.

Reporter-negative disaggregated cells are generally out-proliferated by reporterpositive cells, across multiple 2D cultures. Teratoma-derived reporter-negative cells
mostly died by 3 weeks, with crucial exceptions of viable cells from two teratomas
(Fig.5.3 A,B-bot); infrequent genetic changes in iPSCs are known to limit their use
(Mandai et al., 2017). Reporter-negative A549s from tumors also decreased in percentage
by 3 weeks of culture but then tended to grow (Fig.5.3 C-bot), consistent with robust
persistence of the abnormal cancer cells versus normal iPSCs. Genetic change under the
distinct stresses of 3D is nonetheless highlighted by the uniformly higher percentages of
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reporter-negative cells from freshly harvested teratoma/tumor cells versus 2D cultures of
the same cells. Proliferation under 3D stress in vivo is a likely determinant because
differences in the percentage of RFP-neg cells between the three A549 RFP-LMNB1
clones (Fig.5.3 C-top) correlate with the distinct growth rates of the tumors. Indeed, cell
volume estimates from confocal images (Fig.4.3) allow us to convert measured tumor
sizes at harvest to total cell numbers (N), yielding a much stronger power-law of [% RFPneg] ~ Na (a = 0.44) for in vivo relative to standard in vitro cultures where cells round up
and divide unstressed by the overlying fluid and [% RFP-neg] ~ Nb (b = 0.005) (Fig.5.4
A). A549 clone P3 leads to higher RFP-neg% under in vitro confinement than P1, while
giving lower RFP-neg% with less proliferation in vivo than P1. This indicates that genetic
changes are favored not only by high stiffness but also proliferation (Fig.5.4 A, C). This
is also consistent with our in vitro studies of rigid confinement versus 2D-control (e.g.
Fig.4.10).

To assess myosin-IIA’s role in chromosome loss within solid tissue
microenvironments, teratomas of myosin-IIA knockdown, LMNB1-edited iPSCs were
harvested and disaggregated for comparisons to controls including time-matched 2D
cultures. The latter again showed uniformly low levels of reporter loss, and teratomas
showed the typical 1% loss that increased by ~50% in knockdown cells (Fig.5.4D), which
is consistent with in vitro effects of knockdown in rigid confinement of iPSCs (Fig.4.10).
Whereas solid teratoma masses have the same consistency as subcutaneous tumors rich in
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A

B

D

C
RFP-neg Proportion (%)

✱

1.5

P1

✱✱

P3
1.0

ns
0.5

0.0
Ctrl

Confined

Figure 5.4: Reporter-neg% scales with cell number (N) in a power-law relationship,
and knockdown of Myosin-IIa leads to more reporter-neg% in vivo. (A)-(B)
Chreporter-neg% measured from A549 tumors in Fig 5.3 (C) top was plotted vs cell
number N that is proportional to total division number and is estimated from tumor size
and mean cell volume in vivo. Total cell number of in vitro control was estimated assuming
all the cells are kept, with weekly splitting. The scaling slope in vivo is much higher than
in vitro. (C) Flow cytometry analyses of Chr-5 reporter loss in A549 clone P1 or P3 in
either confined or standard 2D cultures, conducted simultaneously. P3 shows higher Chrreporter% than P1 after confinement. n=3. (D) Myosin-IIA knockdown iPSCs in vivo show
the most Chr-5 reporter-negative cells (RFP-LMNB1) upon disaggregation of solid
teratomas (of shMYH9) when compared to in vivo controls (shCtrl) or time-matched
standard 2D-cultures (in vitro). n=2-3. (C)-(D): two-way ANOVA with Tukey’s correction
for multiple comparisons: *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001; ns, not
significant. D: with Brandon Hayes
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mouse-derived collagen and mouse cells (Swift et al., 2013). Such results are consistent
with the lack of an effect of myosin-IIA inhibition in soft and solid microenvironments.
The findings reaffirm the effects of myosin-II in maintaining genetic stability in rigid
confinement (Fig.4.10), and again offer some insight into how a similar myosin-IIA
knockdown directly in mouse embryo dermis can lead to cancer (Schramek et al., 2014).

5.3 Chr CNV can affect motility of isolated sub-populations

To illustrate use of the fluorescence reporters in relating heritable Chr differences
to phenotype changes, particularly in growth and motility, we applied scRNA-seq to
mixtures of four different A549 clones that are either all positive (P1-P4) or all negative
(N1-N4) for the fluorescent Chr-5 reporter (Fig.5.5 A). Many cancer cells show
spontaneous losses and gains of Chr’s (e.g. Fig. E 2), and bulk DNA profiling shows
clonally distinct CNVs, with the reporter approach providing a unique opportunity for
confidence in finding one less allele of Chr-5 only in (N1-N4) cells (Fig. 5.5A, E2).
However, we expected other CNV-derived phenotype differences in part because P1
tumors grow faster in vivo than P2 and P3 tumors (Fig.5.3 C, Fig. 5.4 A & B). Single-cell
RNA-sequencing profiles showed that Chr-5 have the greatest number of upregulated
genes (>1.28-fold change) when comparing all of the RFP-pos ‘P’ clones to RFP-neg ‘N’
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Figure 5.5: (Previous page) Chr-5 reporter-neg A549 cell clones have genes on Chr-5 down-regulation,
and other chromosome variation (Chr-7) leads to phenotypic changes within reporter-positive
populations as well. (A) Sorting of RFP-pos A549s followed by 3-4 days in standard culture leads to
spontaneous generation of RFP-neg cells that corresponds to Chr-5. Four RFP-pos and four RFP-neg cells
were clonally expanded for genomic characterization, revealing other gains and losses (blue) per the lineage
map. (B) reporter-neg cells show decreased expression of LMNB1 and many other genes on Chr-5 (C) Liveimaging of sparse cultures for 6h on plastic shows persistence scales with migration speed. (D) Mean square
displacement, or random walk movement of P3 is slowed by microtubule or actin disruption, pheno-copying
P1. (E) P1 slow-migration phenotype phenocopied by P3 cells with disruption of microtubules (with Noc) or
F-actin (Lat: latrunculin-A). (F) Cell circularity and aspect ratio in both sparse and crowded culture shows the
expected relationship for an ellipse. P1 cells are again phenocopied by P3 cells treated with Noc or Lat. n>100
cells per condition; *p < 0.05.
B: Sequencing: Yuntao Xia and Jerome Irianto
C: Path graphing:Yuntao Xia
E-F: Fitting: Charlotte Pfeifer

clones (Fig.5.5 B), consistent with a gene dosage effect. Chr-7 segregated P1 from P2-P4,
(Fig.E2). P1 cells migrated more slowly and with less persistence (Fig.5.5 C-E). P3 cells
with depolymerized F-actin or MT followed a similar trend (Fig.5.5 E,F, E3), phenocopying the cytoskeletal deficit in P1 cells. P1 cells were also more rounded than P2-P4,
with circularity closer to 1 (Fig.5.5F). Once again, P3 cells with depolymerized F-actin or
MT followed a similar trend (Fig.5.5F, inset, Fig. E3), pheno-copying the cytoskeletal
deficit in P1 cells. These results － despite being for 2D cultured cells － illustrate P1’s
phenotypic difference from P2’s and P3’s, as observed in vivo (Fig.5.5A).
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5.4 Discussion

The hypothesis that mitosis within rigidly-constraining 3D microenvironments
causes heritable mechanogenetic changes is supported by the mono-allelic chromosome
reporter approach that directly reveals generation of rare GFP/RFP-negative cells that are
to varying extent viable in vivo. Both normal (iPSC) and cancer (A549) reporter cells
harvested from mice display significantly fold-change increase in reporter-neg%,
confirming that high-stiffness environmental structure in vivo yields more genomic
variations. Reporter-neg% in harvested A549 reporter cells dropped dramatically after
undergoing culture in vitro, but this number started to increase before it reached 0. This
indicates that not all–or even a great proportion of genomically altered cells–cannot
survive, and the small proportion that survive are probably enough to lead to the next
generation of mutated cancer cells. Indeed, it is reasonable to judge that Chr-5 reporter neg
cells carry CNV other than Chr-5 and carry complicated heterogeneity, as indicated in our
single cell genomics and karyotyping data (Fig. C1). Chromosomal loss is random, and
many severe lethal CNVs have made cells hard to survive further. iPSCs, on the other hand,
show reporter-neg% dropped to 0 for most of the teratoma, given the difficulty for normal
cells with a lost chromosome to be viable. However, interestingly, one out of ten teratoma
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shows 1% reporter-neg% after long-term culture, providing some possible understanding
on the transition from normal somatic cells to abnormal whose viability and heritability
constitute origins for cancer cell formation and progression.

Scaling of reporter-neg% with respect to cell number (N) gives an estimation on
the trend of how fast CNV changes versus division rate. Total number of divisions includes
all cell divisions that have happened for a single cell to become the total number of cells in
a petri dish or xenograft by the time of measurement (sample calculation A1). The much
greater power exponent in vivo than in vitro confirms the hypothesis that stiff environment
leads to more chromosomal copy number variation, and the increase in reporter-neg%
versus division proves that division is needed for increase in genome variation. This is also
consistent with previous general data showing tissue mutation (reflected by reporter-neg%)
is positively correlated with proliferation (reflected by cell number) and tissue stiffness
(Yizhak, et al., 2019; Beroukhim, et al., 2010; Pfeifer, et al., 2017, Tomasetti and
Vogelstein, 2015, Lawrence et al., 2013). Cells grow much more slowly in vivo than in
vitro, because many initially injected cells couldn’t survive, and also because stiff
confinement slows down division (Lancaster et al., 2013; Fig. D1). Different A549
reporter-pos clones show different Chr-reporter loss levels in vitro and in vivo, and have
different sizes of tumors by the time of dissection. The change of one chromosome is
responsible for the overdose or underdose (insufficiency) of thousands of genes, which, as
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expected, contributes to their different behaviors in migration and ability to live in vivo.
Scrutinizing over those clones show that P1, with an extra copy of q-arm of Chr-7, are
rounder in shape and less likely to migrate in 2D substrate. The central dogma that genotype
affects phenotype has been reflected thoroughly and strictly, while more research can be
executed if Chr-7 is targeted to be a chromosome reporter, in which case the transitioning
from P1 to P3 can be understood and more changes in genotypic and phenotypic levels can
be unveiled and discussed.

In addition, more substrate conditions at different stiffness in between
subcutaneous tumor and liquid tumor (in vitro) can be used to discover a series of power
exponents along with their continuous, functional relationship with stiffness ( Young’s
Modulus E ). If in vivo conditions are hard for controlling stiffness, embedding cells in 3D
gels with specified compositions to control stiffness can be an alternative approach.
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Cell lines and tissue culture.
A549 cells were cultured in Ham’s F-12 media (Gibco 11765047) supplemented with 10%
(v/v) fetal bovine serum (FBS; MilliporeSigma, Catalog no. F2442) and 100 U ml -1
penicillin-streptomycin (Gibco, Catalog no. 15140122). All cells were passaged every 2-3
days using 0.05% Trypsin/EDTA (Gibco, Catalog no. 25300054). All A549 cells were
incubated at 37oC and maintained at 5% CO2.The original A549 RFP-LMNB1 cell line
was engineered by Sigma-Aldrich. The A549 cell line was obtained from the American
Type Culture Collection (ATCC).

The following induced pluripotent stem cell (iPSC) lines were also used, all of
which were acquired from the Coriell Institute for Biomedical Research and
generated/validated by the Allen Institute for Cell Science: iPSC GFP-LMNB1 (AICS0013 cl.210), iPSC RFP-LMNB1 GFP-SEC61B (AICS-0059 cl.36), and iPSC FBL-GFP
NPM1-RFP (AICS-0084 cl.18). iPSCs were cultured in mTseR Plus medium (STEMCELL
Technologies, Catalog no. 05825), with mTser Plus 5X supplement and 100 U ml -1
penicillin-streptomycin. For passaging and maintenance of iPSCs, cells were lifted with
accutase (Sigma, Catalog no. A6964) at 37oC and re-plated into 10-cm plates (Corning)
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coated with Matrigel (Corning, Catalog no. 356231) following the Allen Institute of Cell
Science’s protocol. 10 mM ROCK inhibitor (Y-27632; STEMCELL Technologies,
Catalog no. 72302) was added to replated cultures to help with adherence and to prevent
differentiation. Passaging was done once iPSC cultures reached 70% confluency to prevent
spontaneous differentiation. All iPSC lines were also cultured at 37oC and maintained at
5% CO2.

Monoallelic chromosome tagging
For all attempted monoallelic chromosome reporters as described in Fig. 1E, all donor
constructs were a gift from Allen Institute of Cell Science: AICSDP-8:TOMM20-mEGFP
(Addgene plasmid #87423; http://n2t.net/addgene:87423;

RRID:Addgene_87423),

AICSDP-13:FBL-mEGFP (Addgene plasmid #87427; http://n2t.net/addgene:87427;
RRID:Addgene_87427), AICSDP-35:AAVS1-mEGFP (Addgene plasmid #91565;
http://n2t.net/addgene:91565; RRID:Addgene_91565), AICSDP-42:AAVS1-mTagRFPTCAAX

(Addgene

plasmid

RRID:Addgene_107580),
http://n2t.net/addgene:87420;

#107580;

AICSDP-1:PXN-EGFP

http://n2t.net/addgene:107580;
(Addgene

RRID:Addgene_87420),

plasmid

#87420;

AICSDP-10:LMNB1-mEGFP

(Addgene plasmid #87422; http://n2t.net/addgene:87422;

RRID:Addgene_87422),

AICSDP-52:

plasmid

HIST1H2BJ-mEGFP

(Addgene
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http://n2t.net/addgene:109121 ; RRID:Addgene_109121), AICSDP-7:SEC61B-mEGFP
(Addgene plasmid # 87426; http://n2t.net/addgene:87426; RRID:Addgene_87426).

All knock-in reporter lines were generated following the protocol established in (1)
using CRISPR/Cas9 technology. Donor plasmids were designed such that unique designs
for each target locus contain 5’ and 3’ homology arms (1 kb each) for the desired insertion
site, based on the GRCh38 reference human genome. For editing, we use the ribonucleic
protein (RNP) method with recombinant wild type S. pyogenes Cas9 protein precomplexed with a synthetic CRISPR RNA (crRNA) and a trans-activating crRNA
(tracrRNA) duplex. Recombinant wild-type Cas9 protein was purchased from the
University of California–Berkeley QB3 Macrolab, while crRNA and tracrRNA
oligonucleotides were designed by and purchased from Horizon Discovery. For
transfection of donor templates into target cells, we used the electroporation using a Gene
Pulser Xcell Electroporation System (Bio-Rad). 700,000 targets cells were lifted using
0.05% Trypsin/EDTA, resuspended in 200 ul of fresh media without penicillinstreptomycin, and loaded into a 0.4-cm cuvette. 4 µL of both 10 µM crRNA:tracrRNA
duplex and 10 µM recombinant Cas9 protein were added to the cell solution, as well as 8
µg of donor plasmid. Electroporation conditions were as follows: (1) A549 and H23: 200V
with 45 ms pulse length using a square-wave protocol; (2) U2OS: 160V with 30 ms pulse
length using a square-wave protocol. After electroporation, cells were allowed to expand
for ~1 week and then enriched via fluorescence-activated cell sorting (FACS), as described
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below. 3-5 FACS enrichment cycles were performed to achieve a pure reporter-positive
population.

Single cell RNA-sequencing.
RNA libraries were constructed using the Chromium Single Cell Gene Expression kit
(v3.1, single index, Catalog no. PN-1000128; PN-1000127; PN-1000213) from 10X
Genomics per the manufacturer’s instructions. The libraries were submitted to the
University of Pennsylvania’s Next Generation Sequencing Core for sequencing using
NovaSeq 6000 (100 cycles) from Illumina. Raw base call (BCL) files were analyzed using
CellRanger (version 5.0.1) to generate FASTQ files and the “count” command was used to
generate raw count matrices aligned to GRCh38 provided by 10x genomics. For teratoma
samples, FASTQ files were aligned to both GRCh38 and GRCm38. The cells are labeled
to be human/mouse cells if more than 90% of the UMIs are aligned to GRCh38/GRCm38.
The data generated was imported as a Seurat object (4.0.0) for future downstream analysis
(2). Cells were filtered to make sure that they expressed 500 and 6,000 genes inclusive and
had less than 10 percent mitochondrial content. Data was normalized using the
“LogNormalize'' method or sctransform package (0.3.2) (3). Differential expression
analysis was performed using the “FindAllMarkers'' command and the output was used for
the volcano plot. The very first 30 dimensions were used to generate UMAP. Cell cycle
analysis was performed using “CellCycleScoring'' command.
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Cell type annotations
Raw expression matrices were used as the input for the singleR (1.4.1) package (Aran et
al., 2019). The cell types were annotated based on Human Primary Cell Atlas (Mabbott et
al., 2013).

Reporter validation via single-nucleotide polymorphism arrays & analysis
Genomic DNA was isolated from a minimum of 3.0 ✕ 105 cells with the Blood & Cell
Culture DNA Mini Kit (Qiagen, Catalog no. 13323) per the manufacturer’s instructions. In
the event that cells were either very rare (such as reporter-negative cells) or had poor
viability after FACS enrichment (specifically, iPSCs), genomic DNA was amplified postextraction using the Illustra Single Cell GenomiPhi DNA Amplification Kit (GE
Healthcare Biosciences, Catalog no. 29108107) following the manufacturer’s instructions.
All DNA samples were sent to The Center for Applied Genomics Core in The Children’s
Hospital of Philadelphia, PA, for Single Nucleotide Polymorphism (SNP) array
HumanOmniExpress-24 BeadChip Kit (Illumina). For this array, >700,000 probes have an
average inter-probe distance of ~4kb along the entire genome. For each sample, the
Genomics Core provided the data in the form of GenomeStudio files (Illumina).
Chromosome copy number and LOH regions were analyzed in GenomeStudio by using
cnvPartition plug-in (Illumina). Regions with one chromosome copy number are not
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associated with LOH by Illumina’s algorithm. Hence, regions with one chromosome copy
number as given by the GenomeStudio are added to the LOH region lists. SNP array
experiments also provide genotype data, which was used to give Single Nucleotide
Variation (SNV) data. In order to increase the confidence of LOH data given by the
GenomeStudio, the changes in LOH of each chromosome from each sample were cross
referenced to their corresponding SNV data. After extracting data from GenomeStudio, all
data analysis was done on Matlab.

Lentiviral packaging and delivery
MYH9 silencing was performed by lentiviral-driven expression of short-hairpin RNAs
purchased from Sigma-Aldrich, using the pLKO backbone construct. The following
shRNA

were

used:

TRCN0000285480,

TRCN0000029468,

TRCN0000029466,

TRCN0000276055, and TRCN0000276070. For non-targeting shRNA control, the pLKOsh-HSC plasmid was a gift from Do-Hyung Kim (Addgene plasmid # 46896 ;
http://n2t.net/addgene:46896 ; RRID:Addgene_46896). Lentivirus was produced in
HEK293T cells using MirusBio TransIT-Lenti Transfection Reagent (Catalog no. MIR
6604) following the manufacturer’s protocol. Lentiviral production was allowed to occur
for 48h, after which the supernatant was collected. Lentivirus was concentrated and
purified from traces of fetal bovine serum using the PEG-it Virus Precipitation Solution
(System Biosciences, Catalog no. LV810A-1) following the manufacturer’s protocol.
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Infected cells were selected by incubation using 1 μg ml-1 puromycin (Corning, Catalog
no. 61385RA).

Flow cytometry and FACS
All flow cytometry was performed on a BD LSRII (Benton Dickinson) and analyzed with
FCS Express 7 software (De Novo Software). All studied cell lines were detached by brief
trypsinization (for all cancer lines in 2D culture) or with accutase (for iPSCs and 3Dspheroids), washed, and resuspended in FACS buffer (PBS + 5% FBS) with 1.0 µg ml -1
DAPI (MilliporeSigma, Catalog no. 09542). For all dissociated tumor/teratoma xenograft
quantification of reporter-negative subpopulations, dissociated cells were washed and
resuspended in PBS + 5% (v/v) BSA containing mouse BD Fc Block (Clone 2.4G2; BD
Biosciences, Catalog no. 553141) at a 1:500 dilution of the stock. Cell suspensions were
incubated at 4°C for 30 min and agitated occasionally to prevent cell settling. Once the 30min incubation period elapsed, anti-human IgG (Rockland Immunochemicals, Catalog no.
109-4139) was spiked into the FACS buffer for a final 1:500 dilution. Cell suspensions
were again incubated at 4°C for 30 min and agitated occasionally to prevent cell settling.
Cells were then washed twice with FACS buffer and incubated with a 1:500 dilution of
donkey anti-rabbit AlexaFluor 647-conjugated secondary antibody against the anti-human
IgG in FACS buffer for 30 min at 4°C. Finally, cells were washed twice and resuspended
in FACS buffer containing 1.0 µg ml-1 DAPI. For fluorescence-activated cells sorting, or
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FACS, cells were prepared in the same way as described above except that freshly prepared
sterile FACS buffer was used and no DAPI was included. FACS was performed on either
a BD FACS Aria II or a BD FACS Jazz. Prior to any assay that assessed reporter-negative
subpopulation generation, cells were FACS-enriched for only reporter-positive cells.
Cultures were also routinely FACS-enriched every 2 weeks to remove spontaneous,
naturally occurring aneuploid reporter-negative cells.
For gating, forward scatter parameters FSC-A vs. FSC-H and side scatter
parameters SSC-A vs. SSC-H were used to remove aggregates from analysis. Live cells
were gated on using forward scatter and side scatter (FSC-A vs. SSC-A). DAPI was further
used to discriminate between live cells and debris/dead cells. For tumor/teratoma flow
cytometry quantification, additional gates were added to remove mouse cells from human
xenograft samples. Only anti-human IgG-high cells were gated on. In the case of teratomas,
when possible, a secondary GFP-SEC61B marker unique to the human iPSCs was also
used to further remove any potential mouse cell contaminants in the analysis.

Immunofluorescence and imaging
Cells were fixed in 4% formaldehyde (Thermo Fisher Scientific, Catalog no. 28908) for 15
min, followed by permeabilization by 0.5% Triton-X (MilliporeSigma, Catalog no.
112298) for 15 min, and blocked with 5% bovine serum albumin (BSA; MilliporeSigma,
Catalog no. A7906) for 30 min and overnight incubation in primary antibodies (1:500
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dilution). The cells were then incubated in secondary antibodies (1:500 dilution) for 1.5h,
and their nuclei were stained with 8μM Hoechst 33342 (Thermo Fisher, Catalog no. 62249)
for 15 min. When mounting is involved, Prolong Gold antifade reagent was used
(Invitrogen, Catalog no. P36930). Micronucleated cells were classified manually by
distinct staining by Hoescht 33342 of structures outside of the main nucleus.
Epifluorescence imaging was performed using an Olympus IX71 with a digital camera
(Photometrics) and a 40x/0.6 NA objective. For certain samples, confocal imaging was
performed on a Leica TCS SP8 system with a 63x/1.4 NA oil-immersion. Live imaging
was performed on an EVOS FL Auto Imaging System with 10× or 20x/0.6 NA object in
normal culture conditions (37°C and 5% CO2; complete culture medium as specified
above).

Mouse models and xenograft dissociation
For in vivo studies, non-obese diabetic/severe combined immunodeficient (NOD/SCID)
mice with null expression of interleukin-2 receptor gamma chain (referred to in text as
NSG mice) were used (Alvey et al., 2017). Mice were procured by the University of
Pennsylvania Stem Cell and Xenograft Core. Mouse xenografts were generated in 8- to 12week old NSG mice by subcutaneous or intraperitoneal injection (as a 100 μL bolus) of
approximately 0.5-1.0 ✕ 106 A549 cancer cells (for tumors) or iPSCs (for teratomas). For
injection, cells were resuspended in sterile, serum-free media with Matrigel at a 7:3
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volumetric ratio. Tumor area was calculated as A = 𝛑/4 ✕ L ✕ W, where L and W represent
length and width, respectively. For all in vivo studies, tumor/teratomas were grown up until
they reached ~2-cm in either length or width, after which mice were humanely euthanized.
All mouse experiments were planned with and performed in accordance with protocols
approved by the University of Pennsylvania’s Institutional Animal Care & Use Committee.
For dissociation, tumor/teratomas in humanely euthanized mice were disaggregated
using dispase (Corning, Catalog no. 354235) supplemented with 4 mg ml-1 collagenase IV
(Thermo FIsher Scientific, Catalog no. 17104-019) and DNAse I (Thermo Fisher
Scientific, Catalog no. 18068-015) at 1 µL per 1 mL of dispase solution. Tumor/teratomas
were allowed to dissociate for 30 min while incubated at 37oC. Dissociated cells were
centrifuged at 300✕g, washed with Dulbecco’s phosphate-buffered saline (PBS; Gibco,
Catalog no. 10010-023), and resuspended in ACK lysis buffer to lyse red blood cells. After
lysis, cells were washed once more and used for flow cytometry quantification, single-cell
sequencing experiments, or plated back following the previously described cell culture
methods.

Power-law scaling in vitro and in vivo.
Scaling calculations as depicted in Fig. 4L were done as follows: For cells dissociated from
tumors in vivo, cell number was calculated based on the following equation: N=ρcm/ρm.
Cell density ρc (expressed in number/cm3) was estimated from tumor section images using
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3D reconstruction (ImageJ) from confocal microscopy. Mass density ρm was assumed to
be 1.16 g/cm3. The volume of each tumor was recorded prior to dissociation. For in vitro
cell number calculations, all A549 RFP-LMNB1 clones were cultured for 278 days after
being FACS-enriched and were left unperturbed for the entire duration. Cells were only
passaged at ~70-80% confluency (and at each passaging timepoint, a sample of cells was
analyzed via flow cytometry for reporter-negative quantification). The cell number used
for analysis is the theoretical total number of cells that would have been generated from
the original culture (assuming an infinitely large culture vessel and unlimited nutrients).
For scaling calculation associated with MPS1 inhibition and confinement kinetics in
Fig.4.6, cell number is calculated in similar way as for the theoretical total number
described before. However, doubling time for each conditions are not necessarily the same:
for A549 MPS1 inhibition and DMSO control, cells were seeded at low density and didn’t
reach full confluency before passaging, so the normal doubling time of A549 in this study
(~19 hr) is used; For confinement and its control, however, cells were seeded at semiconfluent density to start, cell number was calculated based on logistic growth function
described in Fig. S5, passaged every 4 days, and assuming all cells dissociated each time
were plated back for the next cycle.

Tumor staining
Sectioning and trichrome staining of A549 tumors were performed by the Molecular
Pathology and Imaging Core (University of Pennsylvania). Tumors were excised, fixed in
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4% formaldehyde overnight at 4°C, washed in PBS, and dehydrated in 70% ethanol prior
to submission. Imaging was done using an Olympus IX inverted microscope with a 40x/0.6
NA or 20x/0.4 NA objective and equipped with a sCMOS camera or a Leica TCS SP8
system with a 63X/1.4 NA oil-immersion (provided and maintained by the University of
Pennsylvania Cell & Developmental Biology Microscopy Core).

Live-cell imaging of cell motility
All studied A549 RFP-LMNB1 clones were plated 24h prior to assay at a density of 4,000
cells per well in a 12-well plate (Corning). Live-imaging was done using an EVOS FL
Auto Imaging System with a 10x objective with cells under normal culture conditions
(37°C and 5% CO2; complete culture medium). One image was every hour for a total of 6
hours. Migration paths of cells were traced with MATLAB, with the original location of
cells labeled as the origin coordinate (0,0). Speed was calculated using the ImageJ Plugin
MtrackJ. For each cell, its location was tracked from t = 0 to 6 h at 1h intervals, and their
2D locations (𝑥𝑖 , 𝑦𝑖 ) were recorded by MtrackJ and exported into excel. The mean speed
for each cell at 6 hour span was calculated as the summation of all paths traveled divided
by time span. Mathematically, 𝑆𝑝𝑒𝑒𝑑 =

∑6𝑖=1 √(𝑥𝑖 −𝑥𝑖−1 )2 +( 𝑦𝑖 −𝑦𝑖−1 )2
6 ℎ𝑟

, where i denotes the

time frame for each cell imaged. Persistence length of each type of clone or condition was
̅
𝐷

calculated as 𝑃 = ̅̅̅
.
|𝐯|̅
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Data reporting
Statistical methods were not used to predetermine sample size. The experiments were not
randomized. Investigators were not blinded to allocation during experiments and outcome
assessment.

Statistics and reproducibility
The statistical methods for each experiment are included in the corresponding Figure
legends. All statistical analyses were done on GraphPad Prism 9.0. All experiments were
biologically repeated and confirmed. Unless otherwise mentioned, all plots show MEAN
± SEM, and statistical comparisons are considered significant if p<0.05. n indicates the
number of samples, cells, wells, etc. quantified in each experiment. Additionally, at least
two separate investigators performed each experiment separately for reproducibility.
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Supplementary materials for chapter 1
Kuangzheng Zhu performed calculation in this supplementary chapter.
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A.1 Sample Calculations
Sample Calculation A.1: Estimation of bacteria and human genetic mutation rate in
mutation per site per cell generation.
Bacteria or unicellular eukaryotes carry out 0.003 mutations per genome per cell
generation (Drake et al., 1998). Bacterial genome is estimated to range from 0.6 to 6
megabases (Fournier and Raoult, 2017).
𝑚𝑢𝑡𝑎𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒 =

0.003 𝑚𝑢𝑡𝑎𝑡𝑖𝑜𝑛𝑠 𝑝𝑒𝑟 𝑔𝑒𝑛𝑜𝑚𝑒 𝑝𝑒𝑟 𝑐𝑒𝑙𝑙 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛
0.6 𝑡𝑜 6×106 𝑏𝑎𝑠𝑒𝑠

=5× 10−9 𝑡𝑜 5 × 10−10

mutation per base (or site) per cell generation, in the order of magnitude of scale of
10−9 to 10−10 .
The number of cells in a new born infant is about 1 trillion (Osgood, 1955).
Total number of cell divisions that have occurred to form the infant constitute the total
number of cell generations for each biological generation. In order to form 2𝑛 cells,
𝑖
∑𝑛−1
𝑖=1 2 divisions are needed. Each division, regardless of direct or indirect contribution

to the formation of final cells, has mutation chances. Therefore, the total number of
𝑖
𝑛
divisions is the geometric series ∑𝑛−1
𝑖=1 2 , evaluated to be 2 − 1. In this study, cell

number for each condition is greater than 1 million, so 2𝑛 − 1 can be treated as 2𝑛 , where
cell number can be treated as identical to total division numbers. With one trillion cells in
new born infant, there have been 1 trillion divisions occurred. Therefore,
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𝑚𝑢𝑡𝑎𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒 =

10−8 𝑚𝑢𝑡𝑎𝑡𝑖𝑜𝑛𝑠 𝑝𝑒𝑟 𝑠𝑖𝑡𝑒 𝑝𝑒𝑟 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛
1012 𝑐𝑒𝑙𝑙 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛 𝑝𝑒𝑟 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑖𝑜𝑛

=10−20 mutation per site per cell

generation. This is an underestimation in that daughter cells formed from division but
died are not counted, and the mutations occur after infant is born are also part of
biological generation but is neglected here. The following schematic diagram shows how
division number and cell number correlate:

1
2

……

22
……

2𝑛

136

Appendix B
Supplementary materials for chapter 2
Data in Fig. B.1 to B.3 in this chapter have been published in Nuclear rupture at sites of
high curvature compromises retention of DNA repair factors. The Journal of Cell Biology,
2018, 217(11), 3796–3808, by Xia, Y., Ivanovska, I.L., Zhu, K., Smith, L., Irianto, J.,
Pfeifer, C.R., Alvey, C.M., Ji, J., Liu, D., Cho, S., Bennett, R.R., Liu, A.J., Greenberg,
R.A., Discher, D.E.; Fig. B.5 images have been recorded in Live cell monitoring for factors
affecting genome variation, Biorxiv, 2018, by Xia, Y., Zhu, K., Irianto, J., Andrechak, J.C., Dooling,
L.J., Pfeifer, C.R., Discher, D.E.. Dr.Yuntao Xia conducted Fig. B.2, B.3 A and C;
Kuangzheng Zhu conducted Fig. B.1, B.3 B, B.4, B.5.
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B.1 Supplementary Figures

Figure B.1: Repair factor relocates into nucleus more slowly than NLS. KU80 is still in the
cytoplasm (arrow) when YFP-NLS is fully within the nucleus, indicating that YFP-NLS may
recover faster than KU80 after rupture. In contrast, both GFP-53BP1 and KU80 are seen in
cytoplasm together (bar graph), indicating these two may recover at similar rates.
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A

B

C

Figure B.2: Ruptured nuclei exhibit an excess in DNA damage marker. (A) Lamin A
knockdown increases the fraction of cells with mislocalized cytoplasmic KU80 and excess DNA
damage as indicated by γH2AX foci. GFP-LMNA rescues both effects. γH2AX foci in nuclei of
shLMNA cells are not enriched near lamina rupture sites (arrows). n > 150 cells in three
experiments. scale bar = 10 µm. (B) For shLMNA cells, ruptured nuclei with higher
cytoplasmic/nuclear KU80 have higher γH2AX foci counts compared with nonruptured ones
with low cytoplasmic/nuclear KU80. Ctl and GFP-LMNA–rescued cells rarely rupture and show
low cytoplasmic/nuclear KU80 and low γH2AX foci counts. n > 150 cells in three experiments.
(C) Comet assay shows higher DNA damage level in A549 shLMNA cells. n > 100 nuclei in
three experiments. (A)-(C): *p < 0.05.

139

B. Supplementary materials for chapter 2

A

C

B

Figure B.3: Not all repair factors are essential; change in stiffness in substrate or
contractility can alter cell shape with lamina amount change. (A) Either knockdown or
overexpression of 53BP1 does not change γH2AX foci count. n > 100 cells in three
experiments. (B) Lamin A level of A549 Ctl cells is mechanosensitive, but A549 shLMNA
cells have low lamin A even on stiff substrate. (C) Nuclear circularity versus nuclear area of
A549 Ctl and shLMNA cells on plastic with/without Blebbistatin treatment. Nuclear
circularity decreases after siLMNA in U2OS cells. n > 50 cells per group in three
experiments. * p < 0.05, n.s., not significant.
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Figure B.4: SNPa of the 3 clones from repair-factor knockdown A549 cell bulk culture.
CN values were subtracted from a control clone. All 3 clones show unidentical genomes.
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Ctrl

normal (87%)

abnormal

(13%)
si3

Figure B.5: Repair-factor knockdown leads to chromosome mis-segregation
during mitosis. A549 cells were treated with combinatory siRNA of KU80, BRCA1,
and BRCA2, or siCtrl, respectively. They were synchronized with nocodazole, and
then released, fixed, and imaged under confocal microscopy. Anaphase cells with
lagging chromosome (abnormal division) is identified to be more in repair-factor
knockdown than Ctrl. All Scale bars = 10 µm.
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Fig. C.1 A-C have been recorded in Live cell monitoring for factors affecting genome
variation, Biorxiv, 2018, by Xia, Y., Zhu, K., Irianto, J., Andrechak, J.C., Dooling, L.J., Pfeifer,
C.R., Discher, D.E.. Dr. Yuntao Xia, conducted Fig. C.1 B; Dr. Jerome Irianto developed
code for SNPa sequencing. Mai Wang did sequencing for Fig. C.1 D; Kuangzheng Zhu
prepared cells for Fig. C.1 D and conducted the rest.
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C.1 Supplementary Figures

A

RFP-LMNB1-

B

RFP-LMNB1- RFP-

D

RFP-LMNB1-

C

Figure C.1: Other validations of Chr-5 reporter
loss from A549 cells: (A) Karyotyping shows
reporter-neg cells have 2 instead of 3 copies of
Chr-5 as in the pos. (B) PCR done with primers
with the forward starting in the middle of RFPgene while backward starting in the middle of
LMNB1 gene, showing the signal only in reporterpos cells. (C) Western blot shows RFPLMNB1
only exists in reporter-pos cells, while endogenous
no-fluorescence LMNB1 exits in both. (D) Singlecell DNA sequencing reveals both expected and
unexpected chromosome (Chr) losses and gains in
A549 cells with the RFP-LMNB1 reporter, after
isolation via FACS. Each row shows the whole
genome at 1.5 Mb resolution for one of 61 RFPpos or 140 RFP-neg cells. D: sequencing: Mai
Wang
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Figure C.2: SNPa validation of other cell lines and Chr-reporters. (A) iPSGFPFBLreporter-neg. (B) Confinement-generated A549-Chr-5 reporter-negs. (C) tumorgenerated A549 reporter-negs; (D) GFPLMNB1 reporter-negs from H23 treated with
reversine. It loses q-arm of Chr-5. (E) GFPLMNB1 reporter-negs from U2OS cells
treated with reversine. It loses part of q-arm of Chr-5, which contains the gene of
LMNB1.
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Figure C.3: SNPa examples of genes that failed Chr-reporter validation. Images show
CTNNB1-GFP as an example, in which fluorescence was lost but genomic validation showed
no copy number variation in the tagged chromosome between the reporter-positive and
reporter-negative samples. Scalebar = 10 µm.

146

C.1 Supplementary Figures

A

C

B

Figure C.4: Rare multi-chromosomal loss can be accurately detected using Chr-reporters.(A)
A549 cells with dual-reporters on single alleles of Chr-5 (RFP-LMNB1) and Chr-19 (GFP-FBL),
respectively, grown on plastic, show spontaneous loss of one or both reporters. (B) Double negative
cells from quadrant III were sorted, expanded, and CNV was measured by subtracting from double
positive SNPa. (C) Images of cells sorted and expanded from quadrant III (double negative) versus
quadrant I (double positive).
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Appendix D
Supplementary materials for chapter 4
Kuangzheng Zhu executed all the experiments and analyses in this supplementary chapter.

D.1 Supplementary Figures
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Figure D.1: High dose MPS1i (reversine) leads to more reporter-neg%; high dose
MPS1i and confinement both lead to slower cell growth. (A) A549 Chr-5 reporter
neg% measured at different times and different MPS1i concentrations, measured with
flow cytometry. (B) Sustained MPS1 inhibition (0.1uM Reversine treatment without
release) impedes net cell growth beyond 2 days (~2 divisions) in sparse culture. Fits are
simple exponential. (C) Sustained confinement for 3 days suppresses proliferation and
kills cells. Cells were seeded at typical semi-confluent density used for confinement, and
were synchronized with nocodazole beforehand, and the measurement started after
nocodazole release of the dense cultures. Mathematical fits are logistic (for control) or
exponential decay (for confined), with initial time delays. Doubling Time indicated in
control (19 hr) is based on the assumption of low density, or, in other words, directly
𝐿
calculated from the coefficient k from logistic model 𝑦 =
(t is expressed
(−𝑘
(𝐴 𝐸𝑥𝑝

in hour)
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D.2 Supplementary Figures

Figure D.2: (Previous page) Confinement increases chromatin area, allows cells to
proceed mitosis, and doesn’t provide additive effect with nocodazole when
superimposed. (A) Representative Images of GFPH2B-tagged A549 cells dividing in both
unconfined and confined cases. Images in horizontal row represents the mitotic procedure of
a single cell. GFP channel with H2B is displayed as DNA tracker. (B) Nuclear area increases
after cells dividing to enter interphase, whether confinement is applied or not. Confinement
enlarges nuclear areas in mitotic phases by 20%, but doesn’t make a difference once cells
enter interphase. (C) Representative images of GFP-H2B A549 cells dividing under
confinement (with 6.58 μm beads). The horizontal row represents the mitotic process of a
single cell. The GFP channel with H2B is used as a DNA tracker. The shape of the RFPLMNB1 signal from the Chr-5 reporters confirms that the displayed cells enter interphase, as
LMNB1 re-assembles in the end. (D) Sub-saturating dose of nocodazole and confinement are
added, without synchronization, displaying no additive reporter-neg% as tested by flow
cytometry. n=3 replicates; two-way ANOVA for multiple comparisons. ***p < 0.0005; ns,
not significant. All Scale bars=10 µm.
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Figure D.3: MPS1 inhibitor reversine leads to more DNA damage in micronuclei.
Ku80 and gH2AX intensity are both higher in reversine-treated micronuclei than DMSO,
indicating higher DNA damage after MPS1 inhibition. n >20 cells per condition; unpaired
two-tailed t-test with Welch’s correction. *p < 0.05, ***p < 0.0005.
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Figure D.4: Mitotic confinement causes some death in mitosis. (A-C) Representative
images of GFP-H2B A549 cells dividing under confinement (with 6.58-μm beads), where
tripolar division, undivided, and dead from start are presented respectively. The horizontal
row represents the mitotic process of a single cell. The GFP channel with H2B is used as a
DNA tracker, while DAPI was added to the culture media to stain for dead cells (or cells
entering apoptosis). Images show an abnormally dividing tripolar cell that survived, an
undivided cell that finally died, and a dead cell at the start of confinement (at t = 0). (D)
Most dead cells during mitosis in confinement (with 6.58-μm beads) are undivided mitotic
cells. Cells dead at the beginning of the process are excluded. All Scalebars = 10 µm.
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D.2 Supplementary Figures

Figure D.5: (Previous page) Myosin-IIa knockdown with collagen-coated substrate increases
loss of chromosome reporter. (A) A549 cells spread on plastic but remain round while firmly
attaching on collagen-coated gel. Scale bar = 50 µm. (B) A549 cells plated on gel have 2.5-fold
longer doubling time than on plastic. (C) Abnormal mitosis is more frequent on collagen-coated gel
versus plastic, in both Myosin-IIa depleted cells and shCtrl cells. n ≥ 10 cells per condition. Scale
bar = 20 µm. (D) RFP-neg proportion and doubling times correlate with detectably abnormal mitosis.
The apparent slope is consistent with 33-fold more losses.(E) DNA is low on collagen-coated gel
(with a decrease in late-S/G2 cells), in both shCtrl and Myosin-IIa depleted cells. Interphase
microtubule organization is altered by collagen-coated gel. n ≥ 40 cells per condition Scale bar =
20 µm. (C) & (E): unpaired two-tailed t-test with Welch’s correction: ***p < 0.0005; **** p <
0.0001.
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Figure D.6: (Previous page) Increased weight leads to increased compression
under confinement, and confinement enlarges cell area: (A) Confinement causes
mitotic height to decrease, while not affecting interphase height, whether Myosin IIa
is knocked down or not. Variation is larger in mitosis than interphase, and chromatin
height in both the tallest and shortest mitotic cells are compressed by confinement.
Increased force causes decreased height after Myosin Iia knockdown. n ≥ 13 cells
per condition. (B) Decreased height corresponds to increased area, confinement
causes cell area to increase. n ≥ 29 cells per condition. (A) & (B): unpaired twotailed t-test with Welch’s correction: ***p<0.05, **** p<0.0001. scale bars = 10 µm.
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D.2 Sample Calculations

Sample Calculation D.1: Derivation of reporter-neg% under perturbation or
release.
Defining the density of reporter positive cells and negative cells are 𝐶𝑝 and 𝐶𝑛 ,
expressed as cell numbers/unit area of vessel surface. Both positive and negative cells
undergo net proliferation with rate constants 𝐾𝑝 and 𝐾𝑛 , respectively. Positive cells can
become negative by losing chromosome with fluorescence loss through “reaction rate
constant” 𝑘𝑙 , while negatives cannot turn back to positive, so the reaction is irreversible.
Therefore, cell number balance gives differential equations:
𝑑𝐶𝑝
= 𝐾𝑝 𝐶𝑝 − 𝑘𝑙 𝐶𝑝 𝐶𝑝 (0ሻ = 𝐶𝑝0
𝑑𝑡

(1ሻ

𝑑𝐶𝑛
= 𝐾𝑛 𝐶𝑛 + 𝑘𝑙 𝐶𝑝 𝐶𝑛 (0ሻ = 𝐶𝑛0
𝑑𝑡

(2ሻ

Solving for (1), there is
𝐶𝑝 = 𝐶𝑝0 𝑒 (𝐾𝑝−𝑘𝑙 )𝑡
Plug in the expression of (1) for (2),
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𝑑𝐶𝑛
− 𝐾𝑛 𝐶𝑛 = 𝑘𝑙 𝐶𝑝 = 𝑘𝑙 𝐶𝑝0 𝑒 (𝐾𝑝−𝑘𝑙 )𝑡
𝑑𝑡
Multiply both sides with 𝑒 −𝐾𝑛𝑡 , there is

𝑒 −𝐾𝑛 𝑡

𝑑𝐶𝑛
− 𝐾𝑛 𝑒 −𝐾𝑛𝑡 𝐶𝑛 = 𝑘𝑙 𝐶𝑝0 𝑒 (𝐾𝑝−𝐾𝑛 −𝑘𝑙 )𝑡
𝑑𝑡
𝑑 (𝐶𝑛 𝑒 −𝐾𝑛 𝑡 ሻ
= 𝑘𝑙 𝐶𝑝0 𝑒 (𝐾𝑝−𝐾𝑛−𝑘𝑙 )𝑡
𝑑𝑡

Integrate on both sides, specifying initial condition 𝐶𝑛 (0ሻ = 𝐶𝑛0

𝐶𝑛 𝑒

𝐶𝑛 =

−𝐾𝑛 𝑡

𝑘𝑙 𝐶𝑝0 𝑒 (𝐾𝑝−𝐾𝑛−𝑘𝑙 )𝑡
=
+𝐶
𝐾𝑝 − 𝐾𝑛 − 𝑘𝑙

𝑘𝑙 𝐶𝑝0 𝑒 (𝐾𝑝−𝑘𝑙 )𝑡
𝑘𝑙 𝐶𝑝0
+ (𝐶𝑛0 −
) 𝑒 𝐾𝑛𝑡
𝐾𝑝 − 𝐾𝑛 − 𝑘𝑙
𝐾𝑝 − 𝐾𝑛 − 𝑘𝑙

Reporter-neg cell proportion in the culture is expressed as:

𝑟 (𝑡 ሻ =

𝐶𝑝
𝐶𝑛
=1−
𝐶𝑝 + 𝐶𝑛
𝐶𝑝 + 𝐶𝑛
𝐶𝑝0 𝑒 (𝐾𝑝−𝑘𝑙 )𝑡

=1−
(𝐶𝑝0 𝑒

(𝐾𝑝 −𝑘𝑙 )𝑡

𝑘𝑙 𝐶𝑝0 𝑒 (𝐾𝑝−𝑘𝑙)𝑡
𝑘𝑙 𝐶𝑝0
+ 𝐾 − 𝐾 − 𝑘 + (𝐶𝑛0 − 𝐾 − 𝐾 − 𝑘 ) 𝑒 𝐾𝑛𝑡
𝑝
𝑛
𝑙
𝑝
𝑛
𝑙

=1
−

𝑘
𝐶
1 + 𝐾 − 𝐾𝑙 − 𝑘 + (𝐶𝑛0
𝑝
𝑛
𝑙
𝑝0

1
𝑘
− 𝐾 − 𝐾𝑙 − 𝑘 ) 𝐸𝑥𝑝[−(𝐾𝑝 − 𝐾𝑛 − 𝑘𝑙 )𝑡]
𝑝
𝑛
𝑙
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Because

𝐶𝑛0
𝐶𝑝0

=

𝐶𝑝0 +𝐶𝑛0
𝐶𝑝0

−1 =

1
𝑟(0ሻ

−1 =

𝑟(0ሻ
1−𝑟(0ሻ

, where 𝑟(0ሻ = 𝑟0, as measured from

flow cytometry , and define ∆𝐾 = 𝐾𝑝 − 𝐾𝑛 ,

𝑟 (𝑡 ሻ = 1 −

1
𝑘
𝑟
𝑘
1 + ∆𝐾 −𝑙 𝑘 + (1 −0𝑟 − ∆𝐾 −𝑙 𝑘 ) 𝐸𝑥𝑝[−(∆𝐾 − 𝑘𝑙 ሻ𝑡]
𝑙
0
𝑙

Parameters are fitted with the expression
𝑟(𝑡ሻ
𝑘𝑙
𝑟0
𝑘𝑙
=
+(
−
) 𝐸𝑥𝑝[−(∆𝐾 − 𝑘𝑙 ሻ𝑡]
1 − 𝑟(𝑡ሻ ∆𝐾 − 𝑘𝑙
1 − 𝑟0 ∆𝐾 − 𝑘𝑙
to determine parameters ∆𝐾 and 𝑘𝑙 .
Reporter-neg% raw data were determined with flow cytometry, and were converted to
absolute ratio (percentage divided by 100) before function fitting. Plotted model is
displayed with 100 multiplied back.

For iPS sample, the generation phase is treated as pulse, instead of a time-dependent
model as presented above.
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Supplementary materials for chapter 5
Fig. E.1 & E.3 A have been recorded in Live cell monitoring for factors affecting genome variation,
Biorxiv, 2018, by Xia, Y., Zhu, K., Irianto, J., Andrechak, J.C., Dooling, L.J., Pfeifer, C.R., Discher, D.E..
Kuangzheng Zhu executed all the experiments and analyses in this supplementary chapter.
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E.1 Supplementary Figures

Figure E.1: iPSCs differentiate after growing in vivo. iPSCs dissociated from teratoma show
high lamin A signal with immunofluorescence, a marker of differentiated cell. scale bar = 100
µm.
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Figure E.2: SNPa of A549 clones involved in in vivo and phenotype studies. P1,P2,P4
and N1,N2,N3,N4 subtracted from P3, leading to a phylogeny map in Fig.5.5A.
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Figure E.3: Motility of genomically different clones of cells can be altered
phenotypically. (A) A549 clones P1-P4 movement tracks in 6 hrs, presented by vectors.
(B) speed of P3 movement slows down when microtubule or actin is disrupted (with
nocodazole or latrunculin, respectively), and pheno-copies the behavior of P1. one-way
ANOVA with Tukey’s correction for multiple comparisons. ****p < 0.0001. scale bar =
100 µm.
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